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Signaling mediated by Notch receptors and their ligands is essential in cell differentiation 
and morphogenesis in metazoans. As both receptors and ligands are cell-surface 
expressed proteins, Notch signaling is restricted to nearby interacting cells. The five 
human ligands of Notch receptors are all single-pass, type I transmembrane proteins 
consisting of an extracellular region involved in receptor binding and of a 100-150 
residue intracellular tail. One of these ligands, Delta-like 4 (DLL4) is a human 
homologue of Drosophila Delta protein, and plays an important role in the development 
of blood vessels. The intracellular region of DLL4 (DLL4_IC) is required for 
receptor/ligand endocytosis, undergoes regulated intra-membrane proteolysis and, 
through its C-terminal PDZ binding motif, mediates he interaction of DLL4 with Dlg-1, 
a protein involved in the organization of cell-cell junctions. The sequence of DLL4_IC is 
very well conserved through evolution but does not encode any domain of known 
structure. Using a recombinant purified protein expr ssed from a codon-optimized 
synthetic gene, we demonstrate through various biophysical methods such as circular 
dichroism, size-exclusion chromatography, and NMR that DLL4_IC is globally 
disordered in solution, but can form inter-convertible local secondary structures in 
response to specific variations in the physico-chemical milieu, as well as in the presence 
of its target PDZ domain. Most of these conformational changes occur in the functionally 
relevant C-terminal segment. A computational study on the incidence and location of 
protein intrinsic disorder in 369 human receptors of the same transmembrane class of 
DLL4 provides evidence that disorder concentrates in the cytoplasmic tail of these 
proteins and represents a general phenomenon. In light of these findings, we propose that 
global disorder in the cytoplasmic tail, in concert wi h local pre-organization, may play a 
role in the function of DLL4 as well as in that of ther single-pass transmembrane 
proteins. 
 3 
List of publications 
 
 
Publications on the subject of this thesis: 
 
1. De Biasio A, Guarnaccia C, Popovic M, Uversky VN, Pintar A, Pong r S. Prevalence 
of intrinsic disorder in the intracellular region of single-pass transmembrane proteins: 
the case of the Notch Ligand Delta-4. J Proteome Res., in press 
 
2. Pintar A, De Biasio A, Popovic M, Ivanova N, Pongor S. The intracellular region of 
Notch ligands: does the tail make the difference? Biol Direct. 2007;2:19. 
 
3. Popovic M, De Biasio A, Pintar A, Pongor S. The intracellular region of the Notch 





This thesis was prepared in the Protein Structure and Bioinformatics Group at the 
International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste, 
Italy, and was supported by an ICGEB predoctoral fellowship. 
 
First, I need to express my gratitude to my superviso , Prof. Sándor Pongor, for his 
advice and care throughout the time I spent in his lab. 
 
I am deeply indebted to Dr. Alessandro Pintar who supervises the studies on Notch 
signaling within the lab, for his day-to-day help an dvice throughout the entire project, 
and especially for his patience in taking me through the challenging yet fascinating field 
of protein NMR. 
 
I am grateful to all the people in the Protein Structure and Bioinformatics Group, for 
having shared hundreds of morning coffees and discussions on international politics and 
ethical issues. 
 
My gratitude goes to Jovana, for sharing the burden of being hostage of the “Trieste 
effect”. Her presence has been central for the results achieved herein. 
 
And, of course, I thank my parents and my sister Anna, for their hope, trust and unlimited 
support. This thesis is dedicated to them. 
 
 5 
Table of Contents 
 
Abstract  2 
List of publications  3 
Acknowledgments 4 
1. Introduction   7 
Notch  Signaling 7 
Mechanism of the core signaling pathway 7 
Notch signaling and cell fate decisions 11 
Non redundant functions of ligands in Notch signaling 11 
Notch ligands: same dog with different tails 12 
Structural biology of Notch ligands 15 
Aim of the work 17 
2. Results 18 
2.1. Structural characterization of the cytoplasmic tail of DLL4 (DLL4_IC)  18 
Sequence analysis  18 
Gene synthesis, protein expression and purification 20 
DLL4_IC is mainly disordered in solution 22 
DLL4_IC displays propensity to form secondary structures 26 
The N-terminal region is not required to for helix formation induced by SDS       31 
The central region is mainly disordered 33 
The C-terminal region displays structural plasticity 35 
 6 
Conclusions 36 
2.2. Studying the interaction between the cytoplasmic tail of DLL4_IC and                     
its target PDZ domain 
37 
PDZ domains: structure and function 37 
DLL4_IC interacts with the first PDZ domain of Dlg-1 in vitro 39 
Expression and purification of the first PDZ domain of Dlg-1 (PDZ1) 42 
The C-terminus of DLL4 interacts with PDZ1  43 
PDZ1 triggers aggregation of DLL4_IC 44 
The titration of PDZ1 with the P3 peptide points to a β-enrichment in the   
peptide 
45 
2.3. Widening the view: intrinsic disorder in single-pass transmembrane  
receptors 
49 
Disorder predictions 49 
Charge/Hydropathy plot 51 
Amino acid compositional analysis 52 
3. Discussion 54 
54 3.1. Intrinsic global disorder and inducible global order in the intracellular tail      
of DLL4: implications in function  
65 3.2. Protein intrinsic disorder in the cytoplasmic tail of single-pass 
transmembrane proteins: a conserved functional role?  







Mechanism of the core signaling pathway 
 
Notch mediated signal transduction controls cell fate (specification, differentiation, 
proliferation and survival) and is a key process in tissue patterning and morphogenesis in 
developing vertebrates and invertebrates 1,2. The main players in this signaling network 
are Notch receptors, four members of which have been id ntified in humans (NTC1, 
NTC2, NTC3, NTC4), and their corresponding ligands, belonging to two distinct 
families: homologues of Drosophila delta protein (Delta-like 1, Delta-like 3 and Delta-
like 4 i) and homologues of Drosophila Serrate, Jagged-1 and -2 (JAG1, JAG2).  
 
 
Figure 1.1 Domain organization of Notch receptors. Human Notch1 (NTC1) is shown as an example. 
Proteolytic cleavage by furin at site S1 produces two subunits, ECN and NTM, which remain non-
covalently associated at the cell surface. EGF-like modules 11 and 12, implicated in ligand binding in 
Drosophila Notch, are shaded. S2 and S3 identify the sites of proteolytic cleavage induced upon activation 
by the ligand. ICN, intracellular domain of Notch; NLS, nuclear localization signal; PEST, proline, 
glutamate, serine, threonine rich sequence; TAD, transactivation domain; TM, transmembrane 3.  
 
                                                
i Delta homologues are also abbreviated as DLL1, DLL3 and DLL4. From here on these abbreviations will 
be used in the text. 
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Notch receptors are membrane-spanning glycoproteins assembled in a non-covalent 
heterodimeric complex (Figure 1.1). The polypeptide encoded by Notch genes is 
proteolytically cleaved in the Golgi during the transport to the cell surface, to give an 
extracellular (ECN) and a transmembrane subunit (NTM). The ECN contains an array of 
29-36 EGF tandem repeats, followed by three LIN-12 repeats that maintain Notch in a 
resting state. The intracellular region of the NTM includes a RAM domain, followed by 
seven ankyrin repeats, a TAD domain, and a PEST region. All Notch ligands share a 
similar architecture (Figure 1.2): a poorly characterized N-terminal region required for 
receptor binding, a Delta/Serrate/Lag-2 (DSL) domain,  variable number of EGF-like 
repeats, a trans-membrane segment, and a relatively short (~100-150 amino acids) 
cytoplasmic tail 4. Jagged ligands have an additional, cysteine-rich region proximal to the 
trans-membrane segment. 
 
Figure 1.2. Domain architecture of Notch ligands. Typical domain organization of Notch ligands: MNLL, 
N-terminal domain; DSL, Delta/Serrate Ligand domain; EGF, Epidermal Growth Factor repeat; VWC, von 
Willebrand Factor type C domain. The transmembrane segment is shown as a blue bar. The number and 
type of EGF repeats can vary. 
 
Notch signaling is initiated by receptor-ligand interactions between two distinct cells. The 
receptor/ligand interaction has not been characterized in detail yet. From deletion studies, 
it has been found that a couple of tandem EGF repeats in the receptor (EGF-11 and -12) 5 
and the DSL domain in the ligand 6 are the minimal requirement for the binding to occur. 
In response to ligand binding, the transmembrane subunit of the receptor (NTM) is 
cleaved by an extracellular ADAM (A Disintegrin and Metalloproteinase) type 
metalloproteinase, 12 residues upstream of the membrane-spanning region. This cleavage 
facilitates a further cleavage of NTM, on the cytoplasmic side. This cleavage is carried 
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out by the presenilin/γ-secretase protease and releases the intracellular domain (ICN) 
from the membrane 7. This series of controlled proteolytic events is refe red to as 
"regulated intramembrane proteolysis" or RIP, and is a signal transduction mechanism 
shared with the adhesion molecules CD44 and nectin-1, the amyloid β-A4 protein, the 
ErbB-4 receptor tyrosine protein kinase, and others. Once translocated into the nucleus, 
the ICN interacts with nuclear factors that activate transcription, the main target being a 
transcription factor (CSL) called CBF1/RBP in mammals, Suppressor of Hairless in 





Figure 1.3. Key biochemical events in the Notch signal transduction pathway. This figure was adapted 
from reference  3. 
 
Notch signaling is regulated at different levels (Figure 1.4): glycosylation of receptors 
and ligands is tuning receptor/ligand recognition 8, cytoplasmic proteins like Numb and 
Deltex play a role in suppressing Notch signal, E3 ubiquitin ligases regulate the level of 
Notch signal by targeting its components for degradation 9, and several nuclear proteins 





Figure 1.4. Regulation of Notch signaling. Binding of Notch receptors to ligands of the Serrate and Delta 
families result in successive cleavages, first in the extracellular domain by ADAM-type proteases, andthen 
in the transmembrane domain by presenilin-dependent proteases, which release ICN and permit its 
translocation to the nucleus. The ability of Serrate-like ligands to activate Notch is antagonized by Fringe 
(FNG) glycosylases, which modify Notch extracellular domains. In the nucleus, ICN activates target gene 
expression by binding the transcription factor CSL, displacing corepressors (CoR), and recruiting 
coactivators (CoA), including mastermind (MAM) (“1”). Poorly characterized CSLindependent pathways 
also exist that may proceed through Dtx (“2”) or unknown factors (“3”). Notch signals are negatively 
regulated by the cytoplasmic protein Numb, and may be positively or negatively regulated by deltex (Dtx) 








Notch signaling and cell-fate decisions 
 
Notch signaling can have many different, if not oppsite effects depending on the timing 
and the tissue context 11,12. For example, while the maintenance of stem cells or 
progenitor cells in an undifferentiated state have be n observed in the hematopoietic 
system and in the pancreas, terminal differentiation is induced in the skin by DLL1 or 
Jagged. In general, Notch signaling is acting on cell fate decisions either through lateral 
signaling or through inductive signaling 1. In lateral signaling, equivalent, equipotent 
cells initially express both Notch receptors and their ligands, but the concentrations of 
these proteins start to differ between neighboring cells perhaps due to fluctuations in the 
steady-state expression levels. Small differences in receptor and/or ligand concentrations 
in cells are amplified over time, leading to cells that exclusively either express the 
receptors or their ligands, thus guiding the specification of the cell fate and cell 
differentiation. In inductive signaling, the interaction occurs between two 
developmentally distinct cells expressing exclusively ithet the receptor or the ligand. 
The fate of the bi-potential precursor cell is decid by the occurence of this interaction, 
while in the absence of Notch signal the precursor cell would follow another fate. The 
cell expressing the receptor, and therefore the recipient of the Notch signal, is induced to 
differentiate into a particular cell lineage. 
 
Non redundant functions of ligands in Notch signaling 
 
 Although the molecular grounds of ligand specificity remain to be determined, in vivo 
studies suggest that each ligand exerts unique and no -redundant effects. Gene knock-out 
of Jagged-1 13 or DLL1 14, heterozygous deletion of DLL4 15, or homozygous mutants in 
Jagged-2 16 all lead to severe developmental defects and embryonic lethality in mice. 
Recently, impressive advances in establishing the role of DLL4 in the development of 
blood vessels have been achieved and several reports showed that the blockade of DLL4 
signaling can inhibit tumor growth by deregulating angiogenesis 17-25 , making DLL4 a 
potential pharmacological target for the treatment of solid tumors 26,27. DLL4/Notch 
signaling can be blocked by either a specific antibody against DLL4 that selectively 
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neutralizes DLL4 or a soluble DLL4 fusion protein tha  works by preventing Notch 
receptors from interacting with endogenous ligands. 
 
Notch ligands: same dog with different tails 
 
Notch ligands are all type I single-pass transmembrane proteins with a common 
architecture (Figure 1.2): an extracellular portion mainly made of globular domains (i.e. 
EGF repeats), required for receptor binding, followed by a transmembrane segment and a 
short intracellular region which does not encode any domain of known structure 4. A 
potentially novel aspect of Notch signaling in mammals has recently emerged and 
underscored the central role of the intracellular region of Notch ligands in several 
mechanisms, such as the interaction with membrane-associated proteins, the endocytic 
processes that control receptor/ligand interactions, a d the signaling in the ligand bearing 
cell, where the ligand cytoplasmic tail acts as a membrane-tethered signaling fragment. 
Our multiple sequence alignments showed that, within the same ligand type, the 
intracellular region of the five Notch ligands (DLL1, DLL3, DLL4, JAG1 and JAG2) is 
well conserved through evolution, while different ligand types show quite distinct 
cytoplasmic tails 28. Sequence conservation within ligand types suggests that precise 
sequence characteristics might be required for specific patterns of post-translational 
modifications to take place and for specific protein-protein interactions to occur 28. The 
functions mediated by the cytoplasmic tail of Notch ligands are described in detail 
hereafter.  
 
The cytoplasmic tail couples Notch ligands to PDZ-containing proteins 
 
 Independent on the interaction with receptors, the cytoplasmic tail of Notch ligands 
couples the Notch signal transduction machinery to PDZ containing, membrane 
associated proteins that play a role in the organization of cell-cell junctions. Jagged-1 has 
been shown to interact with the unique PDZ domain of the ras-binding protein afadin 
(AF6) in a PDZ-dependent manner 29. Dlg-1, the human homologue of the Drosophila 
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Discs Large protein, was identified through peptide-affinity chromatography as a binding 
partner for DLL1 and DLL4 30. It was shown that DLL1/4 can recruit Dlg-1 at cell-cell 
junctions, tighting cell contacts and reducing cell motility 30. The interaction is PDZ-
dependent, although it was not determined which of the three PDZ domains in Dlg-1 
mediates this interaction. In similar studies, the int raction between DLL1 and members 
of the MAGI family (Membrane Associated Guanylate Kinases with Inverted domain 
arrangement) has been reported 31,32. The interaction specifically occurs between the C-
terminus of the Delta proteins and the forth PDZ domain of MAGIs. As there are over 
300 human proteins containing at least one PDZ domain 4,33, it is not clear yet whether 
specific recognition relies on subtle differences in the PDZ domains 34, on a binding 
region larger then the canonical, C-terminal PDZ-binding tetrapeptide 35, or both. 
 
Ubiquitination of the cytoplasmic tail drives endocytosis 
 
The cytoplasmic tail of Notch ligands is also involved in ligand internalization. Although 
in some instances soluble forms of DSL ligands can activate Notch signals, normally an 
intact membrane anchored ligand is required for full activation (Figure 1.5). The current 
hypothesis is that after a receptor/ligand interaction is established, "receptor shedding" is 
required to expose the juxtmembrane region of the rec ptor to proteolytic cleavage 36-38. 
Recent data suggest that  receptor shedding is indeed  promoted by endocytosis of the 
ligand/ECN complex, which physically dissociates Notch1 heterodimers before 
proteolysis can occur 39. The internalization of the ligand/ECN complex is driven by 
mono-ubiquitination of the ligand by the E3 ubiquitin ligase. Whereas in model 
organisms the only apparent function of the intracellular region is to carry lysine residues 
that can be ubiquitinylated to trigger endocytosis 40,41, it seems that in mammals the 
differences in the cytoplasmic tails may underlie more specific mechanisms to control the 
endocytic pathways. In fact, several different E3 ubiq itin ligases that ubiquitinate Notch 
ligands are being identified, and different ligands are specifically recognized by different 













Figure 1.5. Ligand endocytosis. 
 
The cytoplasmic tail of the ligands makes Notch signaling bi-directional 
 
Recent reports show that Notch ligands undergo a proteolytic processing that is strikingly 




Figure 1.6. Bidirectional signaling. 
 
Delta and Jagged undergo ADAM-mediated ectodomain processing followed by 
presenilin/γ-secretase-mediated intramembrane proteolysis to releas  signaling fragments 
44-47. The regulated intramembrane proteolysis, followed by the release from the 
membrane and the localization in the nucleus, suggests a possible role of the intracellular 
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Jagged-1 was able to promote transcription of a report r gene in COS, CHO, and HEK 
cells specifically through the AP1 (Activator Protein 1, p39 jun) enhancer element 46.
Activation by Jagged-1 is at odds with AP1 repression carried out by the intra-cellular 
domain of Notch. There is no experimental evidence, however, that the intra-cellular 
region of Notch ligands can bind DNA directly and, indeed, they do not contain any 
recognizable DNA binding motif. More probably, they function in combination with 
transcriptional complexes or specific transcription factors. Evidence in this direction is 
given by the interaction observed between the mouse DLL1 intracellular region and 
specific Smad transcription factors (Smad-2, -3, and -4) involved in TGF-β/activin 
signaling, that results in a significant enhancement in the transcription of specific genes 
leading to neuronal differentiation of mouse neural stem cells 48. Moreover, co-culture 
experiments showed that DLL1 proteolytic processing a d nuclear localization can be 
enhanced through interaction with Notch1 48. These observations strongly implies the 
existence of Delta signaling, which means that the Notch-Delta signaling pathway is bi-
directional. 
 
Structural biology of Notch ligands 
 
Very little is known about the detailed molecular mechanisms involved in Notch signal 
transduction. Currently, structural studies on Notch signaling are mainly focused on 
proteins playing a role in signal transduction in the signal-receiving cell. The structure of 
a NL (Notch/Lin12) repeat 49, and the structure of the ligand binding region of N tch, 
encompassing three epidermal growth factor repeats 50, have been determined by NMR. 
The structure of Notch ankirin repeats have also been solved 51,52. Of the effector 
proteins, the structure of CSL bound to DNA has been solved by X-ray crystallography 
53. On the other hand, little or no data has been produced concerning the structure of 
Notch ligands or their protein targets in the signal-sending cell. The interaction of Notch 
ligands with their receptors requires the DSL (Delta/Serrate Ligand) domain, but neither 
the structure of this domain nor the mechanism of binding has been determined. Notch 
signaling is sensitive to the concentration of extracellular calcium, but the effect of 
calcium ions on receptor and ligand structure has not been studied yet. Notch 
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receptor/ligand recognition is modulated by glycosylation, but the structural determinants 
that regulate this interaction are not known. Other post-translational modifications, like β-
hydroxylation at aspartic or asparagine residues have been identified, but their role 
remains unclear. Also, the cytoplasmic tails of the Notch ligands, which are multi-task 
structural requirements needed to perform the abovementioned functions (i.e. PDZ 
recognition, ligand endocytosis, intra-membrane proteolysis and transcription co-
activation), are still awaiting a structural characterization. Interestingly, our predictions 
supported by preliminary experimental results point towards a mainly disordered nature 
for the cytoplasmic tail of Notch ligands 28,54,55 (Figure 1.7), suggesting a prominent role 





Figure 1.7. Intrinsic disorder. Disorder in the extracellular (black circles/bars) and intracellular (red 
circles/bars) regions of Notch ligands are shown as (a) a plot of the mean net charge v. the mean 
hydrophobicity and (b) as the percentage of disordered residues calculated by DisEMBL using the "hot 
loops" definition. In (a), the border between folded and natively unfolded proteins is drawn as a line. This 
figure was adapted from reference 28. 
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Aim of the work 
 
The rapidly expanding experimental data underscore the importance of Notch ligands in 
several cellular processes. Most of the recent work has raised many issues on the role of 
the cytoplasmic tail of Notch ligands in bi-directional signaling, in the cross-talk with 
other signaling pathways, in cell-autonomous, Notch-independent signaling, and in 
endocytosis-mediated receptor shedding. Among the five human homologues of Notch 
ligands, DLL4 has proven to be a target of exceptional interest, given its central role in 
blood vessels development and since the blockade of the DLL4-mediated Notch signaling 
can inhibit tumour growth. Moreover, DLL4 couples the Notch signaling network to 
proteins involved in the organization of cell-cell junctions, through the interaction with 
the PDZ domains of Dlg-1 mediated by the ATEV motif located at C-terminus of the 
cytoplasmic tail. The same type of interaction observed between Notch ligand DLL1 and 
Dlg-1 is required to recruit Dlg-1 at the cell membrane, thereby tighting cell contacts and 
reducing cell motility, suggesting a similar role for DLL4 in this process. No structural 
characterization of the cytoplasmic tail of DLL4 has been performed so far. The 
cytoplasmic tail of DLL4 (DLL4_IC, 133 aminoacids) does not encode any domain of 
known structure and the aim of this work is to: (i) assess, through sequence analysis and 
biophysical studies on a recombinant protein, whether DLL4_IC encodes a new globular 
fold or, inversely, if it is partly or entirely disordered and (ii) identify which of the three 
PDZ domains of Dlg-1 interacts with DLL4_IC and study, by making use of a 
recombinant protein encoding the target PDZ domain, how the interaction affects the 
structure of DLL4_IC. Overall, this study will provide important information to describe 
the structural basis of DLL4 action in both the Notch-dependent and independent 








The amino acid sequence (Figure 2.1) of the cytoplasmic region of Notch ligand DLL4 
(DLL4_IC) was subjected to secondary structure and disorder predictions. DLL4_IC is 
expected to adopt some secondary structure, as sugge ted by different secondary structure 
predictors (PSIPRED, JNet, SSpro) 56-58. All tested methods predicted the presence of an 
α-helix in the N-terminal region, starting at R13, and four stretches of β conformation, 
two located after the α-helix and two located at the C-terminus and partially ncluding the 
PDZ binding motif (Figure 2.1). PONDR, a disorder predictor based on neural networks 
trained with sequences of intrinsically disordered gions 59, predicted four disordered 
stretches that account for 37% of the entire sequence of DLL4_IC, whereas DisEMBL, 
another neural network-based predictor, predicted 55% of disordered residues, when the 
Hot-Loop definition of disorder was chosen (see the Materials and Methods chapter for 
details). IUPred 60, which is a disorder predictor that estimates the pairwise energies 
within an amino acid sequence, predicted 56% of disor ered residues. By contrast, as 
expected from the globular nature of the extracellular region of DLL4 (Figure 2.1), the 
disorder prediction carried out on this region computed only 7% (PONDR) and 14% 
(DisEMBL) of disordered residues, while IUPred predicted no disordered regions in the 
extracellular domain. Overall, these predictions suggest a relevant content of protein 
disorder in the cytoplasmic tail of DLL4 together with the propensity of this region to 
adopt local secondary structures.  
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        553                     576  582                                   619                                       662                    685  
      |                       |    |                                     |                                         |                      | 
                              _____________________________________________________________________________________________________________ 
Seq   RQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKELEVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICSPRDSMYQSVCLISEERNECVIATEV 
                                   --------------------------------------******************************************++++++++++++++++++++++++ 
psip  ccccccccccchhhhhhhhhhhhhcccccccceeccceeeeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeeeeeccccccceeeecc 
jnet  cccccccccccchhhhcccccccccccccceeeecccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeeeeeeeccccceeeeecc 
sspro cccccccccccchhhhhhhhhcchccccccceeccccccceeccccccccccccccccccccchcchhhhccccccccccccchhhhcccchccccccccccccccccccccceeeeeeeeccccceeeeeec 
Cons  cccccccccccchhhhhhhhhcchccccccceeecccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeeeeeeeccccceeeeecc 
prob  7667899888865666544445436777654444577645665579988778777778877755665656678788888888776666777677888876667876688887545789985678856788669 
Pondr DDDDDDDDDDDDDDD                                                DDDDDD                  DDDDDDDDDDDDDDDDDDD         DDDDDDDD 
DEMBL DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD                                                 DDDDDDDDDDDDDDDDDDDDDDD        DDDDDDDDDDDDDD 
IPred DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD    DDD               DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD                                  
Delta-like 4  
 DLL4_IC 
Figure 2.1.  Sequence analysis and peptide design. Amino acid sequence of DLL4_IC, secondary structure and disorder predictions. Secondary structure 
predictions (h, helix; e, β-strand; c, coil) were obtained running PSIPRED, JNET and SSpro from the PHYRE web server (http://www.sbg bio.ic.ac.uk/); the 
consensus secondary structure prediction and the scor  are also shown; disorder predictions (D, disordere  residue) using PONDR with the VL-XT predictor, 
DisEMBL according to the Hot-Loop definition and IUPred with the long disorder prediction option. The solid line above the sequence (_) indicates the 
residues included in ∆N-DLL4_IC (res. 576-685). Segments covered by peptides are marked with (--),(P1,res.582-618),(**)(P2,res.619-661),(++)(P3,res.662-
685). 
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Gene synthesis, protein expression and purification 
 
The recombinant protein corresponding to the intracellular region of human DLL4 
(DLL4_IC, residues 553-685 of DLL4_HUMAN, 133 amino acids) was expressed in E. 
coli from a synthetic gene designed to optimize the codon usage for heterologous 
expression (Figure 2.2 and 2.3).  
 
Figure 2.2. Codon usage optimization. Number of codons used in human 
cDNA (white) and in the synthetic gene (black) of DLL4_IC partitioned 
according to their relative abundance in E. coli Class II genes. 
 
Despite an extensive proteolytic degradation, the final material was highly pure (>95%, 
as determined by RP-HPLC), and could be recovered in good yields (8 mg/L), which 
allowed its characterization by circular dichroism, NMR and size exclusion 
chromatography. The truncated protein ∆N-DLL4_IC (see below in the text) was 
expressed in a similar system, and recovery from inclusion bodies allowed for a single 




Figure 2.3. (a) Gene synthesis. Agarose gel (1%) of the gene assembly PCR mixture. Lane 1, 1kb DNA 
ladder plus; lane 2, PCR mixture. (b) Protein purification. Coomassie Blue stained SDS-PAGE (4-12%) of 
DLL4_IC before (lane 2) and after (lane 3) His6-tag removal; lane 1 and 4, LMW markers. (c) Purification 
in native conditions. RP-HPLC analysis of His6-DLL4_IC purified by IMAC followed by ion exchange 
chromatography.  
500 bp- 
- 400 bp- 
- 
 1            2 
(a) 
20 kDa – 
1    2    3    4 
 
(b) 
15 kDa – 
(c) 
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DLL4_IC is mainly disordered in solution 
 
The presence of secondary structure in DLL4_IC was investigated by CD spectroscopy. 
The far-UV CD spectrum of DLL4_IC (Figure 2.4) in Tris buffer shows a strong 
minimum at 198 nm, which is typical of disordered proteins. The deconvolution results 
using CDSSTR show a high content of unordered structu e (77%) and a poor residual 
presence of secondary structure (3% Helix, 10% Strand nd 8% Turns). Very similar 
results were obtained from the CD spectrum of DLL4_IC purified in native conditions 
(Figure 2.3c), confirming that the purification process did not significantly affect the 
intrinsic conformation of DLL4_IC (Figure 2.4). The difference in the intensity of the 
negative band at 198 nm observed in the two spectra is a likely consequence of the poor 
accuracy in the estimation of the concentration from the measured absorbance at 280 nm. 
In fact, as the protein does not contain any Trp residues, this could result in more than 
10% error in the computed extinction coefficient. 
 
Figure 2.4. Circular dichroism. Far-UV CD spectrum of DLL4_IC (7.6 µM) 
in 5 mM Tris-HCl buffer, 1 mM TCEP, pH 7.5, purified in denaturing 
conditions (red trace) and of His6-DLL4_IC (14.1 µM) in 5 mM Phosphate 
buffer, 1 mM TCEP, pH 7.5, purified in native conditions (blue trace). 
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Also, we observed some variability in the β−sheet and turn content in different samples 
and over time, which might reflect the formation ofprotein aggregates and the 
appearance of a subpopulation of molecules enriched with those secondary structural 
elements. This could well be explained by the inherent flexibility of DLL4_IC, which is 
likely to make the protein structurally sensitive to slight fluctuations in the chemical 
environment (e.g. pH, ionic strength or temperature). 
 
The conformation of DLL4_IC was further analyzed by NMR spectroscopy. From the 
1H-15N HSQC spectrum of the 15N-labelled protein, ~100 HN backbone resonances could 
be identified, which correspond to ~80% of the peaks expected, the large majority of 
them being clustered in a narrow region comprised btween 8.0 and 8.5 ppm (Figure 
2.5a). The average value of 1HN chemical shifts (8.27 ppm) is nearly identical and the 
dispersion only slightly larger (σ = 0.18) compared to the values expected for a protein f 
the same amino acid composition and assuming random coil values 61 for all residues 
(8.22 ppm and σ = 0.14, respectively) (Figure 2.5c). The lack of chemical shift 
dispersion in the HN region as well as in the methyl region (data not shown) is an 
indicator of the lack of globular structure, and of little, if any, secondary structure. The 
presence of strong and sharp resonances accompanied by much weaker peaks in the 1H-
15N HSQC spectrum, and the few peaks that could be identified in the HN-Hα region of 
the 1H-15N HSQC-TOCSY spectrum (Figure 2.5b) are also pointing to the presence of 
conformational exchange processes. 
 
In order to better characterize the conformation of DLL4_IC in solution, we studied its 
hydrodynamic properties through size exclusion chromat graphy. DLL4_IC (15 kDa) is 
eluted from the size exclusion column as a peak corresponding to a 31 kDa globular 
protein (Figure 2.6a). The sharpness and symmetry of the peak indicates the presence of 
a single, well defined species. The elution volume of a protein from a size exclusion 
column correlates with its hydrodynamic properties. The hydrodynamic radius (Stokes 
radius, RS) of a protein can be deduced from its apparent molecular weight (MW) as 






Figure 2.5. NMR. (a) 1H-15N HSQC spectra of DLL4_IC (0.5 mM) in H2O/D2O (90/10, v/v), 4 mM TCEP, 
pH 5.6, recorded at 303 K. (b) 1H-15N HSQC-TOCSY of DLL4_IC in H2O/D2O (90/10 v/v) containing 4 
mM TCEP, 2 mM EDTA-d16, 15 mM DSS, pH 5.6, protein concentration ~0.5 mM. The spectrum was 
recorded at 303 K, using a 40 ms mixing time. (c) distribution of 1HN chemical shifts of DLL4_IC in 
H2O/D2O (black bars), in the presence of SDS (grey bars) nd for random coil values for a protein of the 
same amino acid composition (white bars). 
 
The calculated RS for an apparent MW of 31-kDa is 25.3 ± 0.4 Å. The t oretical radius 
of a monomeric protein in either a native or unfolded state (RSN or RSU) can be derived 
from its known molecular size 62. In the case of DLL4_IC, RSN = 19.3 ± 0.3 Å and RSU = 




experimentally determined by size exclusion (25.3 Å), intermediate between RSN and 
RSU, is consistent either with a folded, stable dimer, or with a monomeric, disordered but 
partially compact state. Since both CD and NMR data tend to rule out a folded globular 
state, we interpret size exclusion chromatography results in terms of the presence of a 





Figure 2.6.  Size exclusion chromatography. (a) Elution profile of DLL4_IC on a Sephacryl S-200 column 
(elution buffer: 50 mM Tris-HCl, 100 mM KCl, pH 7.4). The apparent molecular mass of DLL4_IC 
deduced from the column calibration is indicated. (b) Calibration standards are shown as open circles (1, 
lactate dehydrogenase (147 kDa); 2, bovine serum albumin (67 kDa); 3, carbonic anhydrase (29 kDa); 4, 
horse myoglobin (17 kDa)), DLL4_IC as a filled square (apparent MW = 31 kDa). The calibration curve (R 





Taken together, CD, size exclusion chromatography and NMR data are consistent with a 
mainly disordered state of the protein in solution, a d the presence of little or no 
secondary structure.  
 
DLL4_IC displays propensity to form secondary structures 
 
The predictions lead us to speculate that DLL4_IC secondary structure might be 
stabilized by agents promoting native structure or by an artificial 
hydrophilic/hydrophobic interface (SDS micelles). In order to test this possibility, we 
first analyzed the secondary structure of DLL4_IC in the presence of different 
concentrations of TFE, which promotes secondary structu e formation by reducing the 
protein backbone exposure to the aqueous solvent and favoring the formation of intra-
molecular hydrogen bonds 63. Starting from a disordered conformation in aqueous 
solution, a significant change in the secondary structure was observed upon addition of 
increasing amounts of TFE. The CD spectra developed a strong ellipticity at 206 nm and 
a shoulder at 222 nm, characteristic of an α-helical structure, at the expense of the 
minimum at 198 nm (Figure 2.7a). The helical content increases from 3% to 17% upon 
TFE addition (0-20%, v/v), with a drastic change in ellipticity already between 10% and 
15% TFE. Also, a significant increase in β-strand and turns structure is observed in the 
presence of TFE. These results confirm that DLL4_IC has the intrinsic propensity to form 
secondary structures, and the measured content of these is consistent with the predictions. 
 
Similarly, at increasing concentrations of SDS, DLL4_IC undergoes a conformational 
change towards the α-helical structure, reaching a maximum of ~8% of α-helix at 
saturation (10 mM SDS, Figure 2.7b). Interestingly, at the same saturating SDS 
concentration (10 mM), the α-helical content undergoes a significant increase as the pH 
decreases (8% of α-helix at pH 7.5 versus 23% at pH 6.3, Figure 2.7c), while the same 





Figure 2.7. Circular dichroism. Far-UV CD spectra of DLL4_IC (7.6 µM) in 5 mM Tris-HCl buffer, 1 mM 
TCEP, pH 7.5, and in the presence of increasing concentrations of TFE (5, 10, 15, 20 %, v/v) (a or SDS 
(b) or at different pHs  in the presence () or absence (d) of SDS at a super-micellar concentration (10 mM)  
 
 
The SDS-dependent structural change of DLL4_IC is accompanied by its association 
with micelles, as shown by changes in intrinsic fluorescence emission spectra and 
fluorescence anisotropy. An increase in tyrosine fluorescence, observed in the presence 
of SDS, is consistent with the interaction with the micelle surface (Figure 2.8a). The 
binding was saturable with increasing concentrations f SDS (Figure 2.8b). The plot of 
the micelle-induced fluorescence change versus SDS concentration was fitted with a 
quadratic binding equation for a two-state binding of m molecules of DLL4_IC to a 
micelle of n SDS molecules (see Materials and Methods). The detrmined value of the 




SDS molecules, a number that approximates the aggregation number for SDS (i.e. 
number of SDS molecules per micelle). More conclusive values for both the affinity and 
the stoichiometry of the DLL4_IC-SDS micelle complex remain to be determined. The 
titration with SDS reveals that SDS triggers binding below its critical micellar 
concentration (7-10 mM), with a saturated binding around 1 mM for 45 µM DLL4_IC, 
suggesting the possibility that DLL4_IC might drive the formation of SDS micelle while 
binding on its surface, as already seen for α-synuclein, another membrane-interacting 
protein 64. 
 
Figure 2.8.  Fluorescence spectroscopy. (a) Tyrosine fluorescence emission spectra of DLL4_IC (45 µM) 
in 5 mM Tris-HCl buffer, 1 mM TCEP, pH 7.5, in the absence (─) or presence (--) of 10 mM SDS. (b) 
Concentration dependence of DLL4_IC fluorescence increase induced by SDS. The data fitting was 
performed as described in Materials and Methods. (c) Changes in fluorescence anisotropy of DLL4_IC (45 





The binding of DLL4_IC to SDS micelles was further observed by changes in 
fluorescence anisotropy at increasing concentrations f SDS (Figure 2.8c). In fact, 
anisotropy correlates with the diffusive motions of the tyrosine fluorophore and is 
proportional to the size of the rotating molecule: its increase upon SDS addition is 
consistent with the formation of a protein-micelle complex. The binding saturates at 
around 1 mM SDS, confirming the results obtained from the changes in intrinsic 
fluorescence. The secondary structure formation in DLL4_IC observed by CD is 
saturated at a SDS/protein molar ratio (>100:1) significantly higher than that seen to be 
sufficient to saturate the protein-micelle binding as shown by intrinsic fluorescence 
(~20:1). This seemingly discrepant data might indicate that the protein binding to the 
micelle precedes the partial folding on the micelle surface, which can only be reached at a 
certain excess of SDS molecules.  
 
The conformation of DLL4_IC in the presence of SDS micelles was further analyzed by 
NMR. The 1H-15N HSQC spectrum of DLL4_IC obtained at saturating concentrations of 
SDS is somewhat different from that of the protein alone (Figure 2.5a and 2.9a). 
Although several resonances are still missing, probably due to overlap, HN cross-peaks 
appear to be of similar intensity and slightly better dispersed. Most of HN backbone 
resonances are still clustered in a relatively narrow egion (7.7-8.4 ppm), but the average 
value of 1HN chemical shifts (8.11 ppm) is smaller and the dispersion slightly larger (σ = 
0.20) compared to the values obtained for the protein alone (Figure 2.5c). Moreover, ~90 
cross-peaks could be counted in HN-Hα region of the 1H-15N HSQC-TOCSY spectrum 
(Figure 2.9b), most of them in the 4.2-4.6 ppm region. Significantly, a discrete number 
of non-glycine HN-Hα cross-peaks display a high field shift (< 4.2 ppm). The lack of 
significant chemical shift dispersion in the HN and Hα chemical shifts even in the 
presence of SDS micelles is an evidence of lack of tertiary structure. Also, NMR spectra 
suggest that DLL4_IC is conformationally restrained in the presence of SDS micelles.  
Determination of secondary structure, if any, from NMR data is less straightforward. 
Deviations from random coil values in the chemical shifts of 1Hα, 13Cα, and 13C' have 
been widely used to map regions with well defined scondary structure, but require 
residue specific sequential assignments of the backbone resonances. Recently it was 
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shown that also backbone 1HN and 15NH chemical shifts are somewhat sensitive to 




Figure 2.9. NMR. (a) 1H-15N HSQC spectra of DLL4_IC (0.5 mM) in H2O/D2O (90/10, v/v), 4 mM TCEP, 
pH 5.6, recorded at 303 K in the presence of SDS (50 mM); (b) 1H-15N HSQC-TOCSY of DLL4_IC in 
H2O/D2O (90/10 v/v), 50 mM SDS, containing 4 mM TCEP, 2 mM EDTA-d16, 15 mM DSS, pH 5.6, 
protein concentration ~0.5 mM. The spectrum was recorded at 303 K, using a 40 ms mixing time.  
 
presence of SDS might then be explained in terms of partial α-helical formation, 
consistently with CD results. It cannot be ruled out, however, that the negatively charged 
head group of SDS can also contribute to the upfield shift. It has to be noticed that all 
NMR spectra in the presence or absence of SDS were acquired at pH 5.6, a value at 
which the pH-dependent secondary structures in the C-t rminal region of DLL4_IC are 
fully formed (see below). 
(b) (a) 
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The N-terminal region is not required for helix formation induced by SDS 
 
In order to test if the α−helical structure observed in the presence of TFE or SDS is 
located in the N-terminal region as predicted by the secondary predictions (Figure 2.1), 
we  expressed  and  purified a truncated form of DLL4_IC (∆N-DLL4_IC) in which the 
first 23 N-terminal amino acids were deleted. The CD spectrum of ∆N-DLL4_IC alone is 
typical of a disordered protein and is very similar to that of DLL4_IC (Figure 2.10b). By 
addition of increasing amounts of SDS, an increase in the α-helical content is observed 
similar to that seen with DLL4_IC titrated with SDS (data not shown). In fact, at a 
saturating SDS concentration (10 mM), the variation in the helical content in the two 
proteins is very similar (Table 1 and Figure 2.10a and b). Furthermore, the same pH-
dependent increase in α-helix is seen in both proteins (23%). It can be concluded that the 
interaction of DLL4_IC with SDS micelles does not absolutely require the N-terminal 
stretch (res. 553-576) and that the pH-induced helical increase involves residues located 
elsewhere in the sequence. 
On the other hand, the TFE-induced helical increase is more pronounced in the full length 
protein compared to ∆N-DLL4_IC (17% versus 6% in 20% TFE) (Figure 2.10a, b and 
Table 1). Therefore, the N-terminal region is at least partly responsible for the helical 
increase induced by TFE in DLL4_IC. 
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Figure 2.10. CD of the different constructs in buffer, SDS, or TFE. Far-UV CD spectra of (a) DLL4_IC 
(7.6 µM), (b) ∆N-DLL4_IC (10.2 µM), (c) P1 (14 µM), (d) P2 (18.7 µM) and (e) P3 (17.9 µM) in 5 mM 
Tris-HCl buffer, 1 mM TCEP, in the presence of 10 mM SDS at pH 7.5 or 6.0, and in 20% TFE; (f) far-UV 
CD spectra of P3 in Tris buffer 5 mM (pH 7.5 or 6) or 20% TFE. The cylinder on top of each CD spectrum 
represents the full length DLL4_IC and the shaded ar a in the cylinder schematically shows the sequence 
covered by each construct. 
 33 
  H S  T U total NRMSD 
DLL4_IC  buffer pH 7.5 0.03 0.10 0.08 0.77 0.98 0.01 
 buffer pH 6 0.04 0.16 0.11 0.68 0.99 0.02 
 20% TFE 0.17 0.17 0.14 0.53 1.01 0.04 
 10 mM SDS pH 7.5 0.08 0.16 0.13 0.62 0.99 0.02 
 10 mM SDS pH 6 0.23 0.14 0.13 0.51 1.01 0.02 
∆N-DLL4_IC  buffer pH 7.5 0.03 0.19 0.12 0.66 1.00 0.03 
 20% TFE 0.05 0.24 0.17 0.53 0.99 0.03 
 10 mM SDS pH 7.5 0.06 0.25 0.17 0.50 0.98 0.05 
 10 mM SDS pH 6 0.23 0.17 0.15 0.46 1.01 0.02 
P1 buffer pH 7.5 0.01 0.14 0.09 0.74 0.98 0.02 
 20% TFE 0.02 0.12 0.08 0.76 0.98 0.03 
 10 mM SDS pH 7.5 0.02 0.34 0.21 0.41 0.98 0.05 
 10 mM SDS pH 6 0.02 0.31 0.18 0.48 0.99 0.09 
P2 buffer pH 7.5 0.03 0.14 0.10 0.73 1.00 0.02 
 20% TFE 0.08 0.12 0.10 0.70 1.00 0.02 
 10 mM SDS pH 7.5 0.04 0.27 0.16 0.52 0.99 0.02 
 10 mM SDS pH 6 0.04 0.26 0.17 0.51 0.98 0.02 
P3 buffer pH 7.5 -0.09 0.24 0.12 0.63 0.99 0.03 
 buffer pH 6 0.17 0.31 0.22 0.32 1.02 0.02 
 20% TFE 0.06 0.33 0.27 0.34 1.00 0.02 
 10 mM SDS pH 7.5 0.05 0.16 0.11 0.66 0.98 0.05 
 10 mM SDS pH 6 0.40 0.12 0.16 0.31 0.99 0.02 
 
Table 1. Secondary structure analysis. Fraction of secondary structure (H, helix; S, strand; T, turn; U, 
unordered; NRMSD, normalized root mean squared deviation) calculated by CDSSTR from far-UV CD 
spectra. 
 
The central region is mainly disordered 
 
To identify the region of DLL4_IC that undergoes the pH-dependent conformational 
switch in the presence of SDS micelles, we synthesized and studied the conformation of 
three peptides (P1, P2 and P3) that cover the entire DLL4_IC sequence apart for the N-
terminal region. The DLL4_IC sequence was split at proline sites, because of its helix-
breaking properties, and the boundaries were selected taking into account the predictions 
by PONDR (Figure 2.1 and Figure 2.11). According to the fraction of disordered 
residues in the segments relative to each peptide predicted by PONDR, the propensity to 
acquire structure displayed by the three peptides should have the following order: 
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P1>P3>P2. The conformation of the three peptides in buffer alone and in the presence of 
TFE and SDS was studied by far UV-CD spectroscopy and the results from the 
deconvolution of the spectra are summarized in Table 1.  
P1 is disordered in buffer and its conformation is little affected by TFE (Figure 2.10c).  
 
 
Figure 2.11. Peptide design and PONDR prediction of unstructured regions in DLL4_IC. The prediction 
score is plotted against the residue number. Regions with a score higher than 0.5 are considered to be 
disordered. The peptides are represented by the black ars above the residue number axis.  
 
No significant structural change is observed in the pr sence of 10 mM SDS apart for a 
slight increase in strand content (15%), which is pH independent (Figure 2.10c).This 
result is in contrast with the disorder prediction, as the sequence segment that spans P1 is 
predicted by PONDR to be ordered. 
Apart for a slightly higher helical propensity, P2 displays a conformational behavior 
analogous to that of P1 (Figure 2.10d), consistently with the high proline content of this 
region. These results indicate that the pH-induced h lix does not form in the region 






The C-terminal region displays structural plasticity 
 
P3 in Tris buffer at pH 7.5 is mainly disordered (Figure 2.10e), with little strand content. 
TFE induces a relevant conformational change in the peptide, by increasing its strand and 
turns content up to 60%, with no increase in the helical content (Figure 2.10e, Table 1). 
This is consistent with sequence analysis results, which predict two stretches of strand at 
the C-terminus, partially including the PDZ binding motif (Figure 2.1). In the presence 
of 10 mM SDS at pH 7.5, a slight increase in the helical content is observed. This change 
is drastically enhanced when the pH is lowered to 6 (~ 40%, ~10 residues), with a 
concomitant decrease in β-strand content (Figure 2.10e). The conformational switch is 
fully reversed when the pH is raised back to 7.5 (data not shown). These data indicate 
that the pH-dependent conformational switch in P3 in the presence of SDS micelles 
accounts for most of the changes in the CD spectra observed for the full-length 
DLL4_IC, and is due to the formation of a ~10 residue α-helix in the C-terminal region 
(res. 662-685) of DLL4_IC. In the same conditions, a higher number of residues is 
calculated from CDSSTR to be helical in the full length DLL4_IC (~19 residues). 
However, the helical content difference estimated from the mean residue ellipticity at 222 
nm is reduced, suggesting that most of the pH-induce  helix forms indeed at the C-
terminus. When plotting the pH dependence of the helix formation in P3 (Figure 2.12) in 
the  presence of SDS using the ellipticity value at 222 nm, a steep transition at pH ~6.8 
can be spotted (data not shown). Although this pH value is remainder of the pKa of the 
imidazole side chain of histidines, no histidine residue is present in P3. Thus, charge 
neutralization of one or more of the five acidic residues (plus the carboxy-terminus) 
present in P3 is likely to be responsible for the pH-dependent transition. Interestingly, in 
20% TFE, pH 7.5, P3 adopts the same conformation it has in Tris buffer at pH 6 (~60% 
strand+turns, little or no α-helix, Figure 2.10f).  
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Figure 2.12. far-UV CD spectra of P3 (17.9 µM) in 5 mM Tris-






Based on the sequence analysis and experimental data, we can conclude that DLL4_IC is 
globally disordered in solution. However, it can form inter-convertible secondary 
structures (coil, strand and helix) in the C-terminal region that spans the last 24 
aminoacids, depending on the physico-chemical enviro ment. The plastic C-terminus is 
disordered in water at neutral pH but forms a strand-like structure when the pH is slightly 
acidic and in the presence of 20% TFE. Alternatively, at the same slightly acidic pH, it 
adopts a mainly helical conformation in the proximity of the hydrophilic/hydrophobic 
interface of SDS micelles. This C-terminal region is of functional relevance, as it 
includes the type I PDZ binding motif (ATEV) required for the interaction between 
DLL4 and its cognate protein Dlg-1 30. In order to better understand the structural 
grounds of the DLL4/Dlg-1 interaction, first we identified which of the three PDZ 
domains of Dlg-1 interacts with DLL4_IC in vitro, and then, using purified recombinant 
proteins and peptides, we assessed if the disordered conformation of DLL4_IC is affected 
either globally or locally by the interaction with its target PDZ domain.  
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2.2. Studying the interaction between the cytoplasmic tail of DLL4 and 
its target PDZ domain 
 
PDZ domains: structure and function  
 
PDZ domains are the most common protein interaction modules and were originally 
identified in the postsynaptic density protein PSD-95/SAP90 66, Drosophila septate 
junction protein Discs-large and the epithelial tigh  junction protein ZO-1 67, hence the 
acronym PDZ. PDZ domains are highly conserved 80-100 amino acid sequences 
specialized for binding the C-termini of partner proteins, generally transmembrane 
receptors and channel proteins, and/or other PDZ domains. Such interactions localize 
membrane proteins to specific subcellular domains, thereby enabling the assembly of 
supramolecular complexes. The role of PDZ domains in clustering and localization of 
proteins at the plasma membrane has relevant biological implications (e.g. in signaling, in 
ion transport, in mediating the adhesive properties of particular cells and in the formation 
of the specialized intercellular barriers known as tight junctions). 
 
The structure of PDZ domains (Figure 2.13) includes six β-strands (βA–βF) and two α-
helices (αA and αB), which fold into a six-stranded β-sandwich domain (Figure 2.13A). 
As the amino and carboxyl-termini of PDZ domains are close together, the incorporation 
of the domain into different multi-domain proteins is easy 68. PDZ domains specifically 
recognize short carboxy terminal peptide motifs of about five residues. These sequences 
are often found in the cytoplasmic tails of transmembrane receptors and channels 69. 
Peptide ligands bind in an extended groove between strand βB and helix αB, hence 
forming an additional antiparallel β-strand within the PDZ domain (Figure 2.13). This 
mechanism is referred to as β-strand addition 70. The structure of the PDZ domain is not 
significantly affected by the binding to the ligand. The crystal structures of complexed 
and peptide-free third PDZ domain of PSD-95 are almost identical, showing RMSD 
between the α carbon atoms of 0.9 Å 71. 
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Figure 2.13. Structure of the PDZ domain bound to peptide and internal peptide motif. 
A. Ribbon representation of the third PDZ domain of PSD95 (blue) with KQTSV peptide forming 
antiparallel β-sheet with βB strand (red arrow) (PDB code 1be9). Numering of β-strands and α-helices is 
shown. B. Complex of the syntrophin PDZ domain (shown as blue and green solvent-accessible surface 
representation) and nNOS PDZ domain (shown as red ribbon representation with β-finger indicated) (PDB 
code 1qav). This figure was adapted from reference 72. 
 
The specificity of the interactions between PDZ domains and their ligands is imparted 
primarily by the sequence of the C-terminus of the ligand. Specifically, the specificity has 
been traditionally attributed to the last three residues of the ligand (i.e. positions P-0, P-1, 
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P-2, counting backwards from the terminal residue in the ligand). A classification of 
PDZ-binding motifs in the C-termini has been proposed, in which the consensus 
sequence for type I is S/T–X–Φ, and for type II is Φ–X–Φ (where Φ is any hydrophobic 
residue), with the corresponding PDZ-domain classified into type I or type II binding 73. 
 
DLL4_IC interacts with the first PDZ domain of Dlg-1 in vitro 
 
Dlg-1, a human homologue of the Drosophila Discs large tumor suppressor which is a 
member of the membrane-associated guanylate kinase family of molecular scaffolds, is a 
97 kDa protein that bears different protein recognitio  domains, including a SH3 domain, 




Figure 2.14. Schematic representation of full-length and deleted mutant Dlg proteins. NT refers to the 
amino-terminal region of the Dlg protein prior to the first PDZ domain; NT-PDZ1 mutant, aa 1–276 of the 
reported sequence; NT-PDZ12, aa 1–382; NT-PDZ123, aa 1–511 PDZ123, aa 186–511; SH3,  Src 
homology 3 domain; GuK, guanylate kinase homologous region.  
 
In order to identify which of the three PDZ domains of Dlg-1 interacts with the 
cytoplasmic tail of DLL4, we generated different Dlg-1 constructs, shown schematically 
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in Figure 2.14. The Dlg-1 proteins were 35S radiolabeled and in vitro-translated with 
rabbit reticulocyte lysate and incubated in the presence of the purified recombinant His-
tagged DLL4_IC protein previously immobilized on sepharose nickel beads. The results 
of this pull-down assay shown in Figure 2.15 prove that DLL4_IC binds the full length 
Dlg-1 protein weakly, as a faint band could be detect d when the gel was exposed to the 





Figure 2.15. Binding of Dlg to DLL4_IC  in vitro. 35S labeled, in vitro-translated (IVT) Dlg-1 and the 
truncated mutants were incubated at 4 °C in the presence of nickel beads with (+D4) or without (-D4) His6-
DLL4_IC. After extensive washing, the Dlg-1 mutants were eluted from the beads, run on an SDS-PAGE 






However, a much stronger binding is seen between DLL4_IC and the Dlg-1 deletion 
mutant including the first PDZ and the N-terminal region only (NT-PDZ1, Figure 2.15, 
lower panel). The equally strong binding observed btween DLL4_IC and the Dlg-1 
mutant including all three PDZ domains only (PDZ123) confirms that the first PDZ is a 
sufficient recognition determinant in Dlg-1 that binds DLL4_IC in vitro. Surprisingly, the 
NT-PDZ12 and NT-PDZ123 mutants do not show a significant interaction with 
DLL4_IC. A possible explanation of this is that eith r the PDZ domains of those Dlg-1 
mutants are not correctly folded in the in vitro-translation mixture, or the binding site in 
the first PDZ domain is somehow masked by the neighboring PDZ domains when the N-
terminal region is present. The latter behavior could be related to the oligomeric state of 
the Dlg-1 protein, as the N-terminal region contains an L27 domain known to form a 
tetrameric complex in solution 74. These factors could also be at the origin of the weak 
interaction observed with the full length Dlg-1 protein. Although these data do not give 
information on the different affinity of each of the three PDZ domains of Dlg-1 towards 
DLL4_IC, they show that the first PDZ domain (PDZ1) binds DLL4_IC in vitro (Figure 
2.16). We therefore proceeded with the expression and purification of a recombinant 
protein encoding PDZ1.   
 
 
Figure 2.16. Pictorial representation of the interaction between the intracellular domain of Delta-4 and the 






Expression and purification of the first PDZ domain of Dlg-1 (PDZ1) 
 
The recombinant protein corresponding to the first PDZ domain of rat Dlg-1 (PDZ1, 
residues 221-311 of DLG1_RAT) was expressed in E. coli with an hexahistidine tag at 
the C-terminus. The protein was purified to homogeinity (10 mg/L) with a single IMAC 
step followed by a desalting step (Figure 2.17a). The correct folding of the protein was 
assessed by far UV-CD spectroscopy (Figure 2.17b). The deconvolution of the spectrum 
using CDSSTR computed 19% helical and 26% beta sheet residues, while the Stride 
assignment from the PDB file of the NMR solved structure reports 16% and 26% of those 











The C-terminus of DLL4 interacts with PDZ1  
 
The in vivo interaction between DLL4 and Dlg-1 requires the tetrapeptide (ATEV) 
located at the extreme C-terminus of DLL4 30 (Figure 2.16). Using NMR spectroscopy, 
we showed that the C-terminal region spanning the last 24 amino acids of DLL4 (P3 
peptide) interacts with the first PDZ domain of Dlg-1. The assay was performed by 
recording the 1H-15N heteronuclear single-quantum correlation (HSQC) spectra of the 
purified and uniformely 15N labeled PDZ1 protein on addition of substechiometric 
amounts of unlabeled P3 peptide. In the course of the titration, the majority of the 
resonances shifted (red peaks in Figure 2.18) in the spectra, whereas some peaks 
disappeared and a small new set of peaks appeared. The resonance shift increased 
proportionally to the increasing amounts of peptide, suggesting a fast exchange on the 
NMR time scale between the free and peptide-bound form of the PDZ. 
 
 
Figure 2.18. NMR spectroscopy. Overlay of the plot of the HSQC spectra of the free PDZ1 (black) and the 
P3 peptide-saturated form of the protein (red). 
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PDZ1 triggers aggregation of DLL4_IC 
 
One important question that arises from the present findings is: does the globally 
disordered DLL4_IC protein acquire structure upon interaction with its PDZ target? We 
addressed this by titrating the 15N labeled DLL4_IC protein with increasing amounts of 
unlabeled PDZ1, and then we recorded the HSQC spectra of the mixture. In fact, a 
change in the pattern of the N-H cross-peaks in the spectra in the presence of PDZ1 
would point to a structural transition in DLL4_IC. Surprisingly, upon addition of 
substoichiometric amounts of PDZ1, the resonances of the 15N-coupled protons disappear 
from the spectrum, with a complete disappearance obs rved already at a molar ratio of 
1:20 (Figure 2.19a). It must be noticed that no precipitate could be se n in the sample 


















Figure 2.19. NMR spectroscopy. (a) First 1D-1H spectrum from the 1H-15N HSQC spectrum of 15N-
DLL4_IC (1.2 mM); (b) 1D-1H spectrum of the DLL4_IC/PDZ1 (1:1) mixture (0.4 mM); (c) 1D-1H1 
spectrum of PDZ1 (0.6 mM) alone. All samples were ppared in the same buffer (20 mM phosphate, 5 
mM TCEP, 100 mM KCl, pH 5.6). The spectra show the amide proton region only. 
(a) 
(c) (b) 
      ppm       9.0           8.0           7.0          6.0                 9.0            8.0            7.0           6.0 
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The line broadening beyond detection of the DLL4_IC N-H resonance signals is probably 
due to the formation of high molecular weight species that involve DLL4_IC. On the 
other hand, the 1D-1H spectrum of the PDZ1-DLL4 mixture is very similar to that of the 
PDZ1 alone (Figure 2.19c and d), with the resonances in the amide region well disper ed 
and clearly visible: this suggests that the high molecular weight aggregates are likely to 
originate from oligomerization of DLL4_IC. Based onthis experiment only, we cannot 
describe in detail how the conformation of DLL4_IC is affected by the interaction with 
PDZ1. Nonetheless, we can propose that, at least at the concentrations required by this 
experiment, the PDZ1 domain acts as nucleation site for the aggregation of DLL4_IC. 
 
The titration of PDZ1 with the P3 peptide points to a β-strand enrichment in the 
peptide 
 
Our findings suggest that PDZ1 forces DLL4_IC into an aggregated, still soluble state.  
In order to be able to explain the mechanism that underlies this surprising phenomenon, 
one should first identify which region of DLL4_IC mediates the aggregation process 
triggered by the PDZ1 domain. The sequence analysis and conformational studies on 
DLL4_IC showed that its C-terminal region (P3) has a relevant tendency to adopt a β-
strand conformation that could originate from both intra-molecular (β-hairpin 
conformation) and inter-molecular (fibril-like conformation) interactions. A β-strand 
enrichment is often observed in disordered peptides that undergo aggregation processes 
and fibril formation 77. Therefore, we wondered if the P3 peptide might adopt the same β-
strand conformation in the presence of PDZ1: this would be consistent with the observed 
aggregation of DLL4_IC resulting from the interaction with PDZ1, and would suggest 
that the C-terminal region of DLL4_IC is the region that mediates the aggregation 
process.  
 
In order to assess this, we titrated the recombinant PDZ1 domain with increasing amounts 
of P3 peptide, and evaluated the secondary structure ontent of the mixture by far-UV 
CD spectroscopy. The conformation of PDZ1 alone is typical of ordered proteins and the 
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secondary structural content is in agreement with that reported in the literature, while the 
P3 peptide displays a spectrum typical of disordere proteins (Figure 2.20a). After 
mixing PDZ1 with a molar excess of P3, the observed CD spectra of the mixture differ 
from the corresponding theoretical sum curve calculted from the individual spectra 
(Figure 2.20b). Since the theoretical curve corresponds to the spectrum that would be 
observed if no structural variations occur, deviations from these curves are indicative of 
structural transitions. In particular, an increase of the negative band at 219 nm and of the 
positive band at 190 nm is observed upon complex formation: these variations point to a 
gain in beta structure. However, the deconvolution of the spectrum of the complex and 
that of the theoretical sum could not discriminate ny significant difference in the 
secondary structure content. Since these structural va iations are of small entity, in the 















Figure 2.20. far-UV CD spectra of P3 (15 µM) and PDZ1 (10 µM) in 5 mM Tris-HCl buffer, 1 mM TCEP, 
alone (a, blue and black trace, respectively) or mixed (b, black trace). The theoretical spectrum of the sum
of the individual spectra shown in (a) is the yellow trace in (b). 
 
Interestingly, when PDZ1 is titrated with increasing excesses of P3, the band at 190 nm 
and that at 219 nm increase proportionally to the amount of peptide (Figure 2.21a). This 
(a) (b) 
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observation is surprising since, bearing in mind that t e stoichiometry of the reaction is 
1:1 and that the peptide alone is in the random coil conformation (Figure 2.21b), in these 
saturating conditions one would expect to see the opposite trend, with a major 
contribution of the negative band at 198 nm due to the unbound peptide that would 
decrease the positive band at 190 nm. If we assume that the P3 peptide is the flexible, 
plastic species that changes its conformation in the mixture with PDZ1, the spectrum 
obtained from the subtraction of the spectrum of the PDZ1 alone from that of the 





















Figure 2.21. (a) far-UV CD spectra of PDZ1 (10 µM) in 5 mM Tris-HCl buffer, 1 mM TCEP, after the 
addition of P3 at the indicated molar excesses; (b) spectra of P3 alone at the indicated molar excesses 
relatively to 10 µM PDZ1, in the same buffer as in (a); (c) spectra shown in (a) after subtraction of that of 





The spectra obtained from this subtraction are significa tly different from those of the 
peptide alone at the same concentrations (Figure 2.21b) and, after normalization for the 
peptide concentration, they all overlay (Figure 2.21d). These normalized spectra closely 
resemble those of P3 in the β-strand-like conformation observed at slightly acidic pH or 
in 20% TFE (Figure 2.10f). Since this β-strand enrichment can be induced in the P3 
peptide by the presence of substoichiometric concentrations of PDZ1, we propose that the 
region of DLL4_IC spanned by P3, which contains the PDZ-interacting motif, mediates 
the aggregation observed in DLL4_IC (Figure 2.19) upon interaction with PDZ1. The 
possible implications of these findings will be discu sed in the Discussion section. 
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2.3. Widening the view: intrinsic disorder in single-pass 
transmembrane receptors 
 
The structural data on the cytoplasmic tail of DLL4 presented here show its intrinsic, 
globally disordered state in solution. Similarly, our previous experimental data on the 
intracellular region of Jagged-1 54,55, together with the analysis of the sequences of the 
other Notch ligands 28, point to a disordered nature of the cytoplasmic tails of these 
proteins. All Notch ligands belong to the class of membrane proteins with a single 
transmembrane helix (single-pass) and the N-terminus located in the extracellular space 
(type I). In order to assess if the high incidence of protein disorder predicted and 
observed in the cytoplasmic region of Notch ligands is a more general phenomenon 
affecting other proteins of the same transmembrane class, we carried out a 
comprehensive computational study on the incidence and location of protein intrinsic 
disorder in 369 human single-pass type I transmembrane eceptors.  
 
Disorder predictions  
 
A dataset of 369 sequences that included all human single-pass receptors was generated 
and subsequently divided into two subsets: the first consisted of the receptors' 
intracellular regions, while the second included the extracellular regions. The location of 
the transmembrane helices for identifying the sequences' boundaries within the subsets 
was assigned according to the Swiss-Prot database. Di Prot 78, the database of protein 
disorder (469 sequences), and a reduced set (1357 sequences) extracted from SCOP 79, a 
database of domains of known structure, were used a control datasets. Intrinsically 
disordered regions in each of these datasets were pr dicted by subjecting the sequences to 
DisEMBL 80. Figure 2.22 shows the fraction of sequences in the datasets versus the 
fraction (≥ 20%) of residues predicted to be disordered. First, a surprisingly high 
incidence of intrinsic disorder is observed in the intracellular subset, as it contains a 
significantly higher fraction of disordered residues r latively to the DisProt dataset. Also, 
the intracellular subset contains on average a higher amount of disordered residues as 
compared to the extracellular subset, with a relevant fraction of mainly (>50% of 
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disordered residues) disordered sequences (13% and 38% according to the Remark465 
and Hot Loop definitions, respectively, as reported in reference 79, whereas in the latter 
the incidence of intrinsic disorder is only slightly higher than that computed for the SCOP 




Figure 2.22. Disorder predictions. Percentage of sequences in datasets (reduced SCOP, Disprot, 
extracellular and intracellular regions of type I single-pass receptors) with a content of predicted disor ered 
residues ≥ 20%. Intrinsically disordered regions were computed by DisEMBL using the Rem465 definition. 
 
 
IUPred predictions are consistent with DisEMBL results. The fraction of disordered 
residues is higher in intracellular regions, as calcul ted from pairwise energies. Overall, 
the % of residues with a IUPred score above the thrshold of 0.5 is 29 and 10 for intra- 
and extracellular regions, respectively. Very similar results were obtained using either the 




Figure 2.23. Disorder predictions. The percentage of residues in the intra- (filled bars) and extracellular 
(empty bars) regions of human single-pass transmembrane receptors with the type I topology is plotted 




A combination of low mean hydropathy and relatively high net charge was shown to 
represent an important prerequisite for the absence of ompact structure in proteins under 
native conditions 81. Consequently, intrinsically disordered proteins generally localize 
within a unique region of the charge/hydropathy phase space, whereas ordered proteins 
cluster in a separate region (grey and green shaded reas in Figure 2.24, respectively) 82. 
In Figure 2.24, we plotted the absolute value of the mean net charge versus the mean 
hydropathy values for the sequences in both the intracellular and extracellular subsets. 
Clearly, the mean net charge/hydropathy of the intracellular regions is broadly distributed 
in the phase space, as compared to that of their extrac llular counterparts, with an 
averagely higher mean net charge and a relatively lower mean hydropathy, suggesting 
that the intracellular regions are more prone to inrinsic disorder. This is consistent with 





Figure 2.24. Charge/Hydropathy plot. The absolute value of the mean net charge is plotted versus the mean 
scaled Kyte-Doolittle hydropathy for the Intracellular Subset (circles) and Extracellular Subset (diamonds). 
The shaded areas contain 90% of the points from the dataset of disordered regions (DisProt, grey) and the 
dataset of domains of known structure (SCOP, green). The border between structured and natively 
disordered proteins is drawn as a line. The charge/hydropathy value relative to DLL4_IC is also shown. 
 
Amino acid compositional analysis 
 
The amino acid compositional analysis confirms these observations. Figure 2.25 shows a 
comparison of the amino acid compositions of the intra- and extracellular subsets along 
with the comparison between the two control datasets (ordered and disordered proteins). 
With few exceptions (see Discussion), the intracellular set is depleted in the order-
promoting residues 83 (W, C, F, I, Y, V, L, N) and enriched in the disorde -promoting 
residues (A, R, G, Q, S, P, E, K) compared to the extracellular set. The same trend is 

























Figure 2.25. Amino acid compositional analysis. Enrichment or depletion in each amin acid type appears 
as a positive or negative bar, respectively. Amino acids are indicated by the single-letter code and ordered 
according to increasing flexibility. Order-promoting residues: W, C, F, I, Y, V, L, N; disorder-promoting 
residues: A, R, G, Q, S, P, E, K; undefined: H, M, T, D. Error bars are also shown. 
 
Taken together, our disorder predictions, charge/hydropathy and compositional analyses 
strongly suggest a major incidence of intrinsic disorder in human single-pass 





3.1. Intrinsic global disorder and inducible local order in the 
intracellular region of DLL4: implications in funct ion 
 
From a biophysical perspective, proteins fall into a structure continuum (Figure 3.1), 
going from tightly packed globular domains, to less ordered structures such as folded 
domains joint by flexible linkers, to collapsed states with a residual content of transient 
secondary structures called “molten globules” to, finally, proteins that in their native, 
intrinsic state appear as highly extended dynamic ensembles. 
 
 
Figure 3.1. The protein structure continuum (figure adapted from reference 85). 
 
Intrinsic disorder in proteins has been shown to be a widespread phenomenon by both 
computational and experimental methods and it is now recognized that a certain protein 
not only can be functional without having a defined three-dimensional structure, but that 
its functionality can lie indeed in its being disorde ed 84,85. Extensive disorder predictions 
to sequences of genomes of increasing complexity reveal d that disorder is the highest in 
eukaryotes 86 and that long disordered regions are mostly found in proteins involved in 
regulation and signaling 87. These two observations were interpreted as the consequence 
of the increased complexity of the regulatory networks in multicellular organisms, where 
   Increasing content of stable 3D structure 
      Unstructured             Molten globule         Linked folded domains           Mostly folded 
 Increasing content of protein disorder 
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the plasticity of disordered regions in highly connected proteins is exploited to bind 


















Figure 3.2. Functional classification scheme of IUPs. The functio  of IUPs stems either directly from their 
capacity to fluctuate freely in a large conformational space (entropic chain functions) or the ability to 
transiently or permanently bind partner molecule(s). Our data suggest that intrinsic disorder in DLL4_IC 
may play a role in displaying motification sites (global disorder) as well as in recognition and binding to 
protein partners (inducible local order). This figure was adapted from reference 89.
IUPs 
entropic chains 
directly function due to 























assist the folding of 
RNA or proteins 
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Intrinsically disordered proteins (IUPs) are usually characterized by a high number of 
charged residues compared to the number of hydrophobic residues, which results in the 
lack of a hydrophobic core, little or no secondary structure elements, high hydrodynamic 
radius, and often a high net charge at physiological pH. From the biophysical point of 
view, IUPs can be considered as polypeptide chains that in physiological conditions are 
sampling a much wider conformational space with respect to globular proteins. It has 
been proposed that this extended sampling can indeed have several advantages. IUPs 
have a much larger interaction surface/volume ratio compared to globular proteins, which 
allows for the accommodation of a relatively high number of docking sites on a relatively 
short polypeptide chain, at the same time reducing the protein volume, therefore the 
molecular crowding. The extended conformational sampling has interesting 
thermodynamic consequences. It enables IUPs to couple folding to binding maintaining 
high specificity and low affinity due to the balance between the enthalpic contribution to 
binding and the opposite entropic effect. Indeed, weak although specific interactions are 
most important in molecular recognition. The “folding upon binding” mechanism is 
especially advantageous in signaling and regulation c texts, where proteins must 
associate and quickly dissociate when the signaling is over. 
 
The Notch ligand DLL4 is a transmembrane protein comp sed of a globular extracellular 
domain responsible for receptor binding and of a short cytoplasmic tail which is a 
structural requirement for Notch bi-directional signaling, for the cross-talk with other 
signaling pathways, for cell-autonomous, Notch-independent signaling, and for 
endocytosis-mediated receptor shedding. The cytoplasmic tail of DLL4 is evolutionary 
very well conserved (Figure 3.3) and does not share any homology with globular 
domains of known structure, therefore the main question we posed was: does it encode a 
yet unknown functional fold or is it entirely or partly unstructured? Our disorder 
predictions together with NMR, CD and size exclusion chromatography data on a 
recombinant purified protein representing the intracellular region of Notch ligand DLL4 
(DLL4_IC) are consistent with a globally disordered, yet quite collapsed state of the 
protein in solution. Therefore, the structural behavior of this protein fragment as a whole 
resembles that of a native molten globule. The observation of inducible transient local 
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structures in DLL4_IC reinforces this view. In fact, despite its lack of a stable tertiary 
structure, our sequence and structural analyses reveal that DLL4_IC has the inherent 
propensity to form local secondary structures. The structural mapping using synthetic 
peptides that map to different regions of the DLL4_IC sequence showed that the 
secondary structures mainly form in the plastic C-terminus of the protein, that they are 
reversible and inter-convertible and can be specifically induced, from a disordered 




Figure 3.3.  Sequence alignments. The sequences of the intracellular tail of the indicated DLL4 
hortologues. were aligned using ClustalW and colored using CINEMA. Acidic residues (D, E) in red; basic 
(K, R) in blue; histidines (H) in light blue; aliphatic (A, V, L, I, M) in white; small hydrophobic (G, P) in 
orange; aromatic (F, Y, W) in magenta; hydroxyl-contai ing (S, T) in dark green; amide containing (N, Q) 
in light green; cysteines (C) in yellow. This figure was taken from reference 28. 
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The coil-to-strand transition 
 
The secondary structure predictions all point to the presence of a short stretch of β-strand 
structure in the C-terminus of DLL4, involving the last twenty amino acids (Figure 3.4). 
This region is very well conserved through species and is of functional relevance, as it 
includes the C-terminal tetrapeptide (ATEV) shown to be required for the interaction 
with the DLL4 physiological partner Dlg-1. 
  
                         CCCCCEEEEEEEECCCCCEEEEECC 
 
DLL4_human               RDSMYQSVCLISEERNECVIATEV- 
ENSMMUP19092_macaque     RDSMYQSVCLISEERNECVIATEV- 
ENSPTRP44880_chimp       RDSMYQSVCLISEERNECVIATEV- 
XM_852991_dog            RDSMYQSVCLISEERNECVIA---- 
DLL4_mouse               RDSMYQSVCLISEERNECVIATEV- 
XM_230472.3_rat          RDSMYQSVCLISEERNECVIATEV- 
ENSBTAP13680_cow         RDSMYQSVCLISEERNECVIATEV- 
ENSMODP234_opossum       RDSMYQSVCLISEERNECVIATEV- 
ENSGALP13851_chicken     RDSMYQSVFVITEERNECIIATEV- 
ENSXETP46649_frog        RDSMYQSIYVIAEERNECVIATEV- 
Q5RGG6_zebrafish         RDSVYQSVFVIAEERSECVIATEV- 
Q4SC13_pufferfish        RDSMYQSVFVIAEERRECVIATEV- 
NEWSINFRUP135910_fugu    RDSMYQSVFVIAEERRECVIATEVR 
 
 
Figure 3.4.  Secondary structure predictions (C, coil; E, strand; H, helix) 
and sequence alignment of the C-terminal region of DLL4 homologues. 
 
The predicted β-strand conformation is in fact observed by far-UV CD spectroscopy, in a 
peptide representing the last 24 amino acid of DLL4 (P3) in water at slightly acidic pH or 
in the presence of 20% of the co-solvent TFE. In addition, our data showed that a similar 
β-strand conformation can be acquired by the peptide n the presence of 
substoichiometric amounts of the first PDZ domain of Dlg-1, which we proved to be the 
specific determinant of Dlg-1 that binds DLL4_IC in vitro. This phenomenon can be 
interpreted in different ways, with accordingly different thermodynamic implications 
important for the binding of DLL4 to Dlg-1. The regulation of the DLL4/Dlg-1 
interaction is functionally relevant, as its proposed role is to recruit Dlg-1 at the cell 
membrane, tightening cell contacts and reducing cell motility 30. 
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(i) the β-strand conformation is intra-molecular (β-hairpin) and preformed in the 
intracellular environment 
 In the available crystal structures, peptides bearing a PDZ recognition motif bind in a 
groove between βB and αB on the surface of the PDZ domain and adopt a β-strand 
conformation, stitched as an additional strand intothe antiparallel β-sheet on the surface 
of the PDZ domain 72. Therefore, a stable β-hairpin at the C-terminus of DLL4, or a 
significant population of molecules in the same conformation, would present the ATEV 
motif in the correct geometry to dock its PDZ target, drastically reducing the entropic 
cost of binding. This view is supported by the CD analysis of the titration of PDZ1 with 
the P3 peptide, in which we show that the fully formed β-strand conformation is observed 
in P3 even at substoichiometric concentrations of PDZ1.  
Alternatively, the β-hairpin could be induced upon binding with the PDZ domain, 
generating a complex with a lower affinity. Subtle changes in the concentration of DLL4 
would direct the binding to Dlg-1 towards one mechanism or the other, thereby tuning the 
formation of the complex.  
Whether a β-hairpin in the C-terminus of DLL4 is preformed in solution could be 
elucidated by recording and analyzing the 2D TOCSY and NOESY NMR spectra of the 
P3 peptide at pH~6 or in the presence of deuterated TFE. It would then be possible to (a) 
investigate the identity, extent, and location of secondary structural elements in the 
peptide quantitatively, based on the inspection of the 13Cα and 1Hα resonance 
assignments (chemical shift index determination), (b) identify the inter-strand Hα-Hα and 
Hα-NH interactions through the analysis of the NOEs, (c) identify the hydrogen-bonded 
amide hydrogens by plotting their chemical shift variations over temperature changes 
(temperature coefficient determination) and (d) assign the peptide residues to a particular 
secondary structure element by measuring the 3JNH-HA  coupling constants.  
Conversely, 15N and 13C edited experiments on the complex between a doubly la eled 
PDZ protein and the P3 peptide would be needed to clarify if the β-structure in the 
peptide is induced in the bound form. Pulse sequences which can filter out the 15N and 
13Cα-bound hydrogen resonances of the PDZ would allow the observation of the peptide 
resonances only. On the other hand, the analysis of the NOEs from the labeled species 
only, would make possible to assign the residues of the peptide that actually make contact 
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with the PDZ domain, and establish if they take part in the formation of some secondary 
structure.  
 
Also, after assignment of the PDZ resonances, the chemical shift tracking of the PDZ 
15N-1H cross peaks upon addition of P3 peptide would allow the determination of the 
surface of the PDZ that interacts with the peptide. This would tell if the interaction 
involves the canonical binding groove only, as observed with other PDZ-interacting 
shorter peptides, or if it extents beyond to other regions of the PDZ domain. This 
information would be potentially important, as additional contacts to PDZ residues away 
from the binding groove are expected to increase the specificity of the binding.  
 
(ii) the β-strand conformation is inter-molecular (fibril-like) and triggered by the PDZ 
protein 
This scenario is supported by the NMR data that show t at substoichiometric amounts of 
PDZ1 protein are sufficient to broaden the DLL4_IC N-H signals beyond detection, 
suggesting the formation of high molecular weight oligomers of DLL4_IC molecules. 
According to this view, the exposed β-strand in the binding groove (βB) of the PDZ 
domain would function as a template that constrains the C-terminus of DLL4 into a β-
strand conformation. This constrained DLL4_IC molecu  would in turn propagate the 
formation of the same β-strand structure to other DLL4_IC molecules, generating high-
molecular weight species. It is tempting to speculate that this phenomenon may be 
somehow connected to the observed clustering of the DLL4/Dlg-1 complex at cell-cell 
junctions 30. However, this could be also a non-specific phenomenon that originates from 
the relatively high protein concentrations required by NMR. Other experiments are 
needed to test this hypothesis. For instance, running the DLL4_IC/PDZ1 mixture at 
different molar ratios through a calibrated size exclusion chromatography column would 






The coil-to-helix transition 
 
The other major local conformation observed in DLL4_IC is helical and can be induced 
with SDS micelles in a slightly acidic buffer. Our data show that DLL4_IC weakly 
associates with micelles while gaining helical structure and are consistent with the 
formation of a ~10 residue α-helix at saturation. Although all secondary structure 
predictions agree with a high propensity of the N-terminus of DLL4_IC to be helical, our 
results prove instead that the pH-dependent helix formation observed with SDS micelles 
involves the 24 carboxy-terminal amino acids (P3 peptid ). We believe that these 
conformational changes are coupled with the protonati  of one or more acidic residues 
in the C-terminal region of DLL4_IC. It is not likely, however, that this partial charge 
neutralization is sufficient to promote complete insertion of the peptide in the 
hydrophobic layer, given the presence of hydrophilic and positively charged residues in 
the sequence spanned by the P3 peptide. SDS micelles provide a hydrophobic/hydrophilic 
interface and can be considered a first approximation of biological lipid membranes. 
Therefore, the mainly helical conformation of DLL4_IC in the presence of SDS may be 
representative of the membrane-bound, uncomplexed form of DLL4. The possible 
biological implications of the pH-dependent conformational change are not known yet. 
Whereas different cell compartments can be associated with different pH values, little is 
known of the biophysical properties of the membrane-cytoplasm interface 90. In an early 
study, fluorescein was used to map the pH distribution in yeast cells, and it was proposed 
that the intracellular pH is not homogenous, but decreases to ~6.0 in proximity of the 
membrane 91. The pH gradient between the membrane interface and the cytosol would be 
generated by the negatively charged head groups of ph spholipids present in the 
membrane of eukaryotic cells. The partial folding of the C-terminus of the cytoplasmic 
tail of DLL4, accompanied by its association with the inner side of the cell membrane, 
may have relevant effects on the function of the ligand in Notch signaling. For instance, it 
would selectively mask certain residues that are pot ntial targets for post-translational 
modifications such as phosphorylation, ubiquitination and glycosylation, and at the same 
time it would leave others exposed for the same modifications. In a similar way, it would 
mask or expose selected binding motifs with respect to binding partners. For instance, it 
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could prevent the interaction with Dlg-1 by masking the ATEV motif. Further studies are 
needed to confirm this hypothesis. In particular, synthetic membranes which can 
reproduce the composition and geometry of biological membranes with a higher accuracy 
(e.g. liposomes composed of mixtures of biomembrane phospholipids), should be used in 
the above studies. 
 
Alternatively, the secondary structures observed in the C-terminus of DLL4 might be 
induced through the binding of DLL4's cytoplasmic tail to other still unknown 
cytoplasmic or nuclear partners, before or after it is cleaved and released as a signaling 
fragment. In this context, the intracellular domain of the DLL4 homologue DLL1 was 
recently shown to act as a transcription-cofactor in the signal-sending cell, as it mediates 
TGF-β/Activin signaling through binding to Smad proteins  the nucleus 48. 
  
The structural randomness present in intrinsically disordered regions is intuitively 
associated with a lack of evolutionary conservation in the amino acid sequence. In fact, 
because disordered regions do not require structural constraints for folding, they have a 
higher degree of mutability as compared to folded domains 92. Expansion of genetically 
unstable repeats has been proposed as a major mechanism for generating novel genetic 
material encoding long disordered regions 93. Bearing in mind this general rule, it seems 
somehow paradoxical that a globally disordered functio al region such as DLL4_IC is on 
the other hand very well conserved across species. Figure 3.3 shows how the 
conservation extends well beyond the PDZ interacting C-terminal motif. We believe that 
this apparently contradicting observation is just the evidence of the intrinsic functional 
role of structural disorder in DLL4_IC, which seems to have been “selected” in 
evolution, through the conservation of the DLL4_IC amino acid sequence. In other 
words, while sequence conservation in DLL4_IC suggests that precise consensus motifs 
are required for specific patterns of post-translational modifications to take place and for 
specific protein-protein interactions to occur, the conservation of structural disorder 
indicates disorder as a fundamental prerequisite for these events to occur. According to 
this view, we propose that the co-existence of global disorder (i.e., lack of a well-defined 
globular structure) and local pre-organization (i.e., the propensity to form certain types of 
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secondary structures locally, either in a stable or transient way), may indeed represent the 
mechanism exploited by DLL4 to carry out its action n both the Notch-dependent and 
independent processes it mediates. Global disorder can impart the structural flexibility 
required to expose specific sites for posttranslation l modifications (phosphorylation, 
ubiquitination or glycosylation) while local pre-organization can guarantee specificity to 
the binding of DLL4 to its intracellular partners, such as Dlg-1. Further studies aimed at 
determining the actual post-translational modifications that DLL4 undergoes, the entire 
spectrum of its interactors together with a structural characterization of the interactions, 





Figure 3.5. Cartoon representation of the possible conformations f the intracellular region of Delta-4 at 
the membrane/cytoplasmic interface; (a) the intracellular tail of Delta-4 is disordered exc pt its extreme C-
terminus which is helical when bound to the inner side of the lipid bilayer; (b) the β-strand structure in the 
C-terminus is intra-molecular and either preformed or induced by the presence of its PDZ target; (c) the β-
strand conformation is induced by the PDZ domain and propagates inter-molecularly causing the 
oligomerization of Delta-4; α-helices and β-strands are represented by cylinders and arrows, respectively; 




3.2. Protein intrinsic disorder in the cytoplasmic tail of single-pass 
transmembrane proteins: a conserved functional role? 
 
Single-pass transmembrane receptors play an important role in cell communication and 
signal transduction. In the simplest functional model, upon binding of a signaling 
molecule to the extracellular region of a receptor, a response is initiated on the inner side 
of the membrane. This response is in fact accomplished by the receptor's intracellular tail. 
An analysis of the modular domain architecture of the human single-pass transmembrane 
receptors dataset (369) by the SMART tool 4 revealed that the majority of the ligand-
binding extracellular regions are composed of known globular domains. On the other 
hand, SMART failed to identify any known domains in 63% of the intracellular regions, 
with the notable exception of receptors containing a kinase domain in their cytoplasmic 
region. This result can be due to either the presence of yet unidentified globular domains, 
or the prevalence of disorder in the intracellular tails of receptors. Our findings indicate 
that ID in the human single-pass transmembrane receptors with the type I topology is 
indeed predominant within the cytoplasmic regions, whereas the extracellular regions 
behave more like ordered proteins. These results are supported by the DisEMBL and 
IUPred predictions, by the plots of mean net charge versus hydropathy, and by the amino 
acid compositional analysis. When considering the mean net charge versus hydropathy 
plot, it should be kept in mind that kinase domains appear with a certain frequency in the 
intracellular region of single-pass receptors, which justifies the occurrence of several 
entries in the right-hand part of the plot, corresponding to ordered proteins. Incidentally, 
we remarked that there is a significant difference in the mean net charge of the 
extracellular and intracellular regions of the human transmembrane proteins analyzed in 
this work. While the majority (81%) of the extracellular regions have a negative mean net 
charge, the intracellular regions are nearly equally distributed between positively (47%) 
and negatively (53%) charged. In fact, most type I transmembrane proteins bear a short 
stretch of positively charged residues in their cytoplasmic tail, in the region close to the 
inner side of the membrane and protruding from it. As the inner leaflet of the membrane 
in eukaryotic cells is negatively charged, the presence of a positively charged segment is 
supposed to be a signal that drives the protein into the correct orientation 94.  
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With respect to the amino acid composition, the interpretation of the results is more 
complex. While the intracellular regions are depleted of several order-promoting residue 
types, such as W, C, F, and V, and enriched in some of the disorder-promoting ones such 
as E and K, the trend observed in the DisProt versus Ordered comparison is not always 
respected. For example, methionine, which belongs to the order-promoting residues, 
displays a high frequency in intracellular regions. It is likely that methionine, as it is 
susceptible to oxidation, prefers the reducing environment of the cytosol, compared to the 
extracellular environment. The different redox potential in the cytoplasm and in the 
extracellular space may also be associated with the diff rent distribution of other amino 
acid types, like cysteine, which is most frequently found in its oxidized half-cystine, 
structure stabilizing form in the extracellular space, and almost exclusively found in its 
reduced form, often coordinated to metal ions, in the intracellular space. Tyrosine, which 
is also an order-promoting amino acid type, is over-represented rather than depleted in 
intracellular regions. We think that a possible explanation is given by the fact that Y is a 
target for phosphorylation, known to be one of the main signaling mechanisms. The 
amino acids E, Q, P, and S are largely over-represent d in disordered regions, but not 
quite so in the intracellular regions of receptors. This is due to the fact that these residues 
are often found in low complexity tracts (poly-glutamic acid, poly-glutamine, poly-
proline and domain linkers, respectively). The intracellular regions appear to be 
disordered, but not compositionally biased in this sense. 
 
Several MIRR (Multichain immune recognition receptors) cytoplasmic domains belong 
to the subset of sequences which predictions failed to ascribe to domains of known 
structure, and they were experimentally proven to be intrinsically disordered 95. 
Previously, we showed that the cytoplasmic tails of all ive human Notch ligands are very 
well conserved within ligand types, display little sequence similarity between one 
another, display no homology with sequences of known fold and are predicted to be 
disordered 28. Moreover, we have shown that a recombinant protein corresponding to the 
intracellular region of the Notch ligand Jagged-1 is actually disordered in solution, while 
it partially folds upon interaction with synthetic membranes made of negatively charged 
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phospholipids 54,55. Jagged-1, similarly to DLL4, couples Notch signali g to PDZ bearing 
proteins. However, differently from what observed for DLL4, the interaction with its 
target PDZ domain does not seem to affect Jagged-1`s globally disordered conformation 
(unpublished data). The secondary structure predictions carried out on Jagged-1 sequence 
differ from those obtained for DLL4 and the other ligands 25. Significantly, predictions of 
posttranslational modification and protein-protein interaction sites are different for each 
of the five ligands (Figure 3.6). While global disorder seems to be a common featur  
shared by all ligands, we believe that the presence of specific patterns of pre-organized 
secondary structures as well as of post-translationl modification and protein-protein 




Figure 3.6. Functional analysis. Potential binding sites and post-translational modifications predicted by 
ELM 96,97, NetPhos 94, and O-glycosylation 98 for the cytoplasmic tail of human Notch ligands. Prediction 
of ubiquitination sites is based on the preference for acidic residues adjacent to the target lysine 99. 14-3-3, 
14-3-3 proteins interacting motif (Ser/Thr phosphorylation required); Cyc, cyclin binding site; FHA, 
forkhead-associated domain interaction motif 1 (Thr p osphorylation required); PDZ, class I, II, or III PDZ 
binding motif; SH2, Src Homology 2 (SH2) domains interaction motif (tyrosine phosphorylation required; 
subtypes include GRB2, SH-PTP2, SRC, STAT3, STAT5, STAT6); SH3, SH3 domains binding motif 
(subtypes include class I, class II, and other non-ca onical motifs); TRAF2, tumor necrosis factor receptor 
associated protein binding motif; Ub, ubiquitination site; WW, WW domain binding motif (subtypes 
include Group I (PPXY), Group II (PPLP), Group III, and Group IV, which requires Ser/Thr 
phosphorylation). Tyrosine-based sorting signals responsible for the interaction with the µ subunit of the 
AP (Adaptor Protein) complex are shown as doughnuts. Potential phosphorylation sites are in red; kinases 
are abbreviated as follows: CDK, Ser/Thr cyclin dependent kinase; CK1, casein kinase 1; CK2, casein 
kinase 2; GSK3, glycogen synthase kinase 3; PKA, protein kinase A; PKB, protein kinase B; PDK, Proline-
Directed Kinase; PLK, Polo-like-kinase. ITIM, immunoreceptor tyrosine-based inhibitory motif (tyrosine 
phosphorylation required); ITSM, immunoreceptor tyrosine-based switch motif (tyrosine phosphorylation 
required). Sites that are candidates for O-glycosylation with β-N-acetylglucosamine are shown as grey 
diamonds; sites that are predicted to be both glycosylated and phosphorylated are shown as black 
diamonds. This figure was taken from reference 28. 
 
Overall, there is convergent evidence that the asymmetric disorder distribution observed 
in DLL4 and its homologues reflects a more general phenomenon in transmembrane 
receptors of the same class, where the extracellular domains are ordered and appear to act 
as rigid scaffolds for ligand binding, while the intracellular tails, which transduce the 
signal within the cell and activate the complex cellular response, have a higher content of 
structural disorder. Consequently, we speculate that the intracellular tails carry out their 
function by binding possibly multiple partners, eith r remaining unstructured, by 
exploiting pre-formed local secondary structures, or through disorder-to-order transitions. 
Further experimental data on the structural characte ization of the interactions between 
the cytoplasmic tails of transmembrane receptors and their partners are needed in order to 
explore this intriguing hypothesis. 
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Materials and Methods 
 
DLL4_IC sequence analysis 
 
The DLL4_IC protein sequence was submitted to the PONDR server 
(http://www.pondr.com) using the default predictor VL-XT 59, the DisEMBL server 
(http://dis.embl.de), and the IUpred 60 server (http://iupred.enzim.hu/). Secondary 





The oligonucleotides for the gene assembly were design d with DNAWorks v2.3 100. The 
amino acid sequence of human Delta-like protein 4 cytoplasmic region (DLL4_IC, 
corresponding to residues 553-685 of DLL4_HUMAN) was backtranslated using the E. 
coli Class II codon usage 101, and the generated DNA sequence (dll4_ic) was divided into 
18 partially overlapping nucleotides with a maximum length of 40 bases, a calculated 
annealing temperature (Tm) of 60ºC, a Tm range of 2.9ºC and a minimal overlap of 13 
bases. The oligonucleotide sequences were designed to have the lowest propensity to 
form hairpins within each oligonucleotide, and to contain no repeats that might lead to 
mispriming in the polymerase chain reaction (PCR). Synthetic oligonucleotides were 
purchased from Sigma-Genosys (0.05 µmol scale) and, after being dissolved in equimolar 
concentration (200 nM), assembled by PCR using Pfu polymerase (Promega) with the 
following forward and reverse primers (MWG-biotech, 0.05 µmol scale) containing the 
wanted restriction sites: 5’-TAA TAG TAG CAT ATG AA CAC CAT CAC CAT CAC 
CAT CGC CAG CTG CGT CTG CGT-3’ (the underlined sequence encodes the start 
methionine, followed by a lysine residue and a six-histidine tag) and 5’-TAG TAG GGA 
TCC TCA TTA AAC TTC AGT TGC GAT CAC GCA CTC ATT ACG TTC-3’, 
respectively. PCR conditions were: 5 min at 95°C (hot start), 25 cycles of amplification 
(30 s denaturation at 95°C, 30 s annealing at 58°C, 90 sec elongation at 72°C), 10 min at 
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72 °C for the final elongation. The assembled and amplified synthetic gene, resulting in a 
sharp band of the correct size in the agarose gel, was digested by Nde I/BamH I, and 
ligated into a pET11a vector using standard procedures. DH5α E. coli cells were 
transformed with the dll4_ic-pET11a construct and selected on LB plates with 100 
µg/mL ampicillin. The positive clones were sequenced by automatic DNA sequencing in 
both forward and reverse directions and the correct one (1/12) used for protein 
expression. 
The nucleotide sequence of the truncated form of DLL4_IC lacking the first 23 amino 
acids (∆N-DLL4_IC) was amplified by PCR from the dll4_ic-pET11a construct with the 
reverse primer used in the DLL4_IC gene synthesis and the following forward primer: 5’- 
TAG TAG TAG CAT ATG AAA GAT AAC CTG ATT CCG-3’. PCR conditions were 
the same as above except for the annealing temperatur  which was set at 58°C. The PCR 
product was digested by Nde I/BamH I, ligated into a pET11a vector, and the construct 
used to transform DH5α E. coli cells. The positive clones were selected as above, 
sequenced in both directions, and the correct one (1/2) used for protein expression.  
 
Protein expression and purification 
 
1) DLL4_IC 
Purification in denaturing conditions. 1 L of LB containing 100 µg/mL ampicillin and 25 
µg/mL chloramphenicol was inoculated with a clone of BL21(DE3)pLysS cells 
transformed with the dll4_ic-pET11a construct. Cells were grown at 37°C to an OD of 
~0.8 and protein expression was induced with IPTG 1 mM for 3 h at room temperature. 
Cells were harvested, washed, and resuspended in the lysis buffer (20 mM phosphate 
buffer, 0.5 M NaCl, 50 mM CHAPS, 2% TWEEN, 5 mM TCEP, protein inhibitor 
cocktail tablet (Roche), 10 mM imidazole, 6 M GuHCl, pH 7.4) and sonicated on ice. 
After centrifugation and filtration through a 0.22 µm filter, the supernatant was loaded on 
a Ni2+ Sepharose His-Trap HP column (1 mL, Amersham Biosciences), the column 
washed with 20 mM phosphate buffer, 0.5 M NaCl, 10 mM imidazole, 5 mM TCEP, 6 M 
GuHCl, pH 7.4, and the protein eluted with a 0.01-0.5 M imidazole gradient. In order to 
remove fragments derived from partial proteolytic degradation, the eluted material was 
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purified by RP-HPLC with a Zorbax 300SB-CN column (9.4 x 250 mm, 5 µm, Agilent) 
using a 0-40% gradient of 0.1% TFA in H2O and 0.1% TFA in CH3CN and freeze-dried. 
The N-terminal His6-tag was removed using a recombinant dipeptidyl aminopeptidase I 
(DAPase) containing a C-terminal His-tag (TAGzyme, Qiagen) for 2 h at 37ºC according 
to the manufacturer’s protocol. An additional IMAC step on a His-Trap HP column (1 
mL) using a 0-0.5 M imidazole gradient removed the peptidase, the partially digested 
protein and the cleaved His2 dipeptides. The protein was subjected to a final RP-HPLC 
step and analyzed by LC-MS on a Gilson HPLC system coupled to an ESI-MS single 
quadrupole mass spectrometer (Applied Biosystems API-150EX), using a Zorbax 300SB-
CN column (2.1 X 150 mm, 5 µm, Agilent) and a 0-50% gradient of 0.1% TFA in H2O 
and 0.1% TFA in CH3CN. Deconvolution of the multicharge ion spectrum was carried 
out using the BioMultiView software (Applied Biosystems). and confirmed the correct 
molecular size of the purified product (Mr calculated: 14894 Da; Mr observed: 14893 
Da). The purified protein was freeze-dried and used for spectroscopic studies. The yield 
was ~8 mg protein per 1 L of culture. 
 
Purification in native conditions. In order to test the possibility that the above hars  
purification conditions (i.e., 6 M GuHCl in lysis and IMAC buffers, RP-HPLC acidic 
buffers [pH~2], freeze-drying process) could irreversibly denature the protein, DLL4_IC 
was also purified in native conditions. Cells were grown and protein expression was 
induced as described above. Cells were then harvested, washed and resuspended in the 
lysis buffer (20 mM phosphate buffer, 0.5 M NaCl, 50 mM CHAPS, 2% TWEEN, 5 mM 
TCEP, protein inhibitor cocktail tablet, 10 mM imidazole, pH 7.4). After the cells had 
been sonicated and spun as described, the supernatant was loaded onto a His-Trap HP 
column, which was washed with 20 mM phosphate buffer, 0.5 M NaCl, 10 mM 
imidazole, 5 mM TCEP, pH 7.4, and the protein eluted with a 0.01-0.5 M imidazole 
gradient. The eluted fractions were pooled and diluted with buffer A (20 mM phosphate 
buffer, 5 mM DTT, pH 7.4). The His6-DLL4_IC protein was purifed by ion-exchange 
chromatography on an 8 x 75 mm SP column (SP-825, Shodex) using a 0-50% gradient 
from buffer A to buffer B (20 mM sodium phosphate, 1 M NaCl, 5 mM DTT, pH 7.4). 
The eluate was concentrated by ultrafiltration on a Centricon 3000 (Amicon), followed 
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by dilution with the final buffer (5 mM phosphate, 1 mM TCEP) for the subsequent 
spectroscopic analysis. Although the protein yield was quite low, the achieved protein 
purity was satisfactory (>95%) and the correct molecular size was confirmed by LC-MS. 
 
15N isotopic enrichment. 1 L of 15N-M9 minimal medium (6 g/L Na2HPO4, 3 g/L 
KH2PO4, 0.5 g/L NaCl, 1.3 g/L glycerol, 0.5 g/L 
15NH4Cl, 0.12 g/L MgSO4, 0.01 g/L 
CaCl2) containing nutrients supplemented as yeast nitrogen base w/o amino acids or 
NH4SO4 (1.7 g/L), pH 7, with 100 µg/mL ampicillin and 25 µg/mL chloramphenicol was 
inoculated with a clone of BL21(DE3)pLysS cells transformed with the dll4_ic-pET11a 
construct. Cells were grown overnight at room temperature to an OD of ~0.6 and protein 
expression was induced with IPTG (1 mM) for 4.5 h at 37ºC. Protein purification was 
carried out in denaturing conditions as described above, with a final yield of ~8 mg of 
pure product per 1 L of culture 
 
Expression of ∆N-DLL4_IC and purification from inclusion bodies. 1 L of LB containing 
100 µg/mL ampicillin and 25 µg/mL chloramphenicol was inoculated with a clone of 
BL21(DE3)pLysS cells transformed with the ∆N-dll4_IC construct. Cells were grown at 
37°C to an OD of ~0.9 and protein expression induce with IPTG (1 mM) for 3 h at 
37°C. Cells were harvested, washed and resuspended i  the lysis buffer (50 mM Tris-HCl 
buffer, 5 mM EDTA, 0.5% Triton-X100, 0.1 mM PMSF, 1 mM DTT and protein 
inhibitor cocktail tablet (Roche)) and sonicated on ice. After sonication, MgSO4 (10 mM) 
was added to chelate EDTA and the inclusion bodies collected by centrifugation at 6000 
rpm for 15 min. The pellet was washed twice with lysis buffer and an additional wash 
was carried out without Triton-X100. The final inclusion body pellet was resuspended in 
100 mM Tris-HCl, 50 mM Glycine, pH 8.0, dispersed by sonication and dissolved 
dropwise with the same buffer containing urea to a fin l concentration of 6 M urea. The 
urea was eliminated from the solution with a HiPrep 26/10 Desalting column and a final 
purification step was performed using RP-HPLC with a Zorbax 300SB-CN column (9.4 x 
250 mm, 5 µm, Agilent) using a 0-60% gradient of 0.1% TFA in H2O and 0.1% TFA in 
CH3CN. The freeze-dried product was analyzed by LC-MS which confirmed the correct 
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molecular size (Mr calculated: 1267.9 Da; Mr observed: 1265.0 Da).The yield was ~4 mg 
protein (~95% purity) per 1 L of culture. 
 
2) PDZ1 
The DNA encoding the first PDZ domain of rat Dlg-1 (PDZ1, residues 221–31), was 
amplified by PCR from the c-DNA of the full length Dlg-1 mutant used in the in vitro 
binding assay, with the following forward and reverse primers (MWG-biotech, 0.05 µmol 
scale): 5’-TAG TAG CAT ATG GAA TAT GAA GAA ATC ACA-3’ and 5’-TAG TAG 
GGA TCC TCA TTA ATG GTG ATG GTG ATG GTG TTT CCT TCT TTT TAC 
ATA-3’ (the underlined sequence encodes a six-histidine tag), respectively. PCR 
conditions were: 5 min at 95°C (hot start), 25 cycles of amplification (30 s denaturation 
at 95°C, 30 s annealing at 36°C, 90 sec elongation t 72°C), 10 min at 72 °C for the final 
elongation. The PCR product was cloned into the Nde I/BamHI sites of a pET11a vector. 
1 L of LB containing 100 µg/mL ampicillin was inoculated with a clone of BL21(DE3) 
cells transformed with the PDZ1-pET11a construct. Cells were grown at 37°C to an OD 
of ~0.8 and protein expression was induced with IPTG 1 mM for 3 h at room 
temperature. Cells were harvested, washed, and resusp nded in the lysis buffer (20 mM 
phosphate buffer, 0.5 M NaCl, 50 mM CHAPS, 2% TWEEN, 5 mM TCEP, protein 
inhibitor cocktail tablet (Roche), 10 mM imidazole, pH 7.4) and sonicated on ice. After 
centrifugation and filtration through a 0.22 µm filter, the supernatant was loaded on a 
Ni2+ Sepharose His-Trap HP column (1 mL, Amersham Biosciences), the column washed 
with 20 mM phosphate buffer, 0.5 M NaCl, 10 mM imidazole, 5 mM TCEP, pH 7.4, and 
the protein eluted with a 0.01-0.5 M imidazole gradient. Imidazole was removed with a 
HiPrep 26/10 Desalting column (Amersham) with a desalting buffer (5 mM Tris, 1 mM 
TCEP, pH 7.4 or 20 mM phosphate buffer, 1mM TCEP, pH 7.4) and the sample 
concentrated with a 15 ml Centriprep column (Amicon). The 15N isotopic enrichment was 
carried out as described for DLL4_IC, by substituting glycerol with glucose (2g/L) in the 
minimal medium. The desalted and concentrated PDZ1 protein was used for the far-UV 






All peptides (P1, res. 582-618; P2, res. 619-661; P3, res. 662-685) were prepared by 
standard solid-phase Fmoc methods using a home-built automatic synthesizer based on a 
Gilson Aspec XL SPE. After cleavage/deprotection of the peptide-resin (preloaded 
NovaSyn TGT, Novabiochem) in TFA/1,2-ethanedithiol/triisopropylsilane/H2O 
90/5/2.5/2.5 v/v/v for 2 h, deprotected, reduced peptid s were purified by semi-
preparative RP-HPLC on a Zorbax 300SB-C18 column (9.4 x 250 mm, 5 µm, Agilent) 
and freeze-dried. P1 was purified using a 0-60% gradient of 0.1% TFA in H2O and 0.1% 
TFA in CH3CN. P2 and P3 were purified using a 0-40% gradient of triethylammonium 
acetate (TEAA) (10 mM, pH 7 in H2O) and TEAA in 80% CH3CN, followed by further 
purification and desalting using a 0-60% gradient of 0.1% TFA in H2O and 0.1% TFA in 
CH3CN. The identity of the peptides was checked by LC-MS and the yield and purity 
estimated from RP-HPLC. Final yields were in the range 40–60% and purity > 95%.  
 
Size exclusion chromatography 
 
The freeze-dried protein powder was dissolved in the elution buffer (50 mM Tris-HCl, 
100 mM KCl, pH 7.4), loaded onto a Sephacryl S-200 column (Pharmacia) and eluted in 
the same elution buffer. The apparent molecular mass of DLL4_IC was deduced from a 
calibration carried out with the following molecular standards: lactate dehydrogenase 
(147 kDa), bovine serum albumin (67 kDa), carbonic anhydrase (29 kDa) and horse 
myoglobin (17 kDa). Stokes radii of native (RSN) and fully unfolded (RSU) proteins of 
known molecular weight (MW) were determined according to the equations described by 
Uversky 62: 
log(RSN) = -(0.254 ± 0.002) + (0.369 ± 0.001) log(MW), and  






Circular dichroism (CD) 
 
The freeze-dried DLL4_IC protein powder was dissolved either in 5 mM MES buffer, 1 
mM TCEP, pH 6.3, or in 5 mM Tris buffer, 1 mM TCEP, pH 7.5. Protein concentration 
was determined by UV absorbance at 280 nm using the calculated ε value of 2560 M-1cm-
1. CD spectra of solutions of DLL4_IC, ∆N-DLL4_IC, PDZ1 or the synthetic peptides, 
were recorded on a Jasco-810 spectropolarimeter in the 190-250 nm range, using quartz 
cuvettes (path length 0.1 cm). Spectra were averaged from 5 scans of 0.1 nm steps at 20-
50 nm/min. The secondary structure analysis was performed using the Dichroweb 102 tool 
CDSSTR. The helical content was also determined from the mean residue ellipticity 
(MRE, deg·cm2/dmol) at 222 nm ([θ]222) according to the equation: [α] = 100·[θ]222/θf and 
θf = -40000·(1-2.57/n) where [α] is the amount of helix, n is the number of residues, and 




The sample for NMR spectroscopy was prepared by dissolving the freeze-dried material 
in H2O/D2O (90/10, v/v) containing 4 mM TCEP, 2 mM EDTA-d16, 15 µM DSS and 
adjusting the pH to 5.6 with small aliquots of 0.1 N NaOH, for a final protein 
concentration of ~0.5 mM. The sample containing SDS was prepared dissolving solid 
SDS sodium salt in the NMR sample, for a final SDS concentration of 50 mM. After 
flushing the NMR tube with argon, spectra were recoded at 303 K on a Bruker 
spectrometer operating at a 1H frequency of 600.13 MHz and equipped with a 1H/13C/15N 
triple resonance Z-axis gradient probe. Transmitter fr quencies in the 1H and 15N 
dimensions were set on the water line and at 118.0 ppm, respectively. HSQC and HSQC-
TOCSY experiments were carried out in phase-sensitive mode using echo/antiecho-TPPI 
gradient selection and 15N decoupling during acquisition. HSQC spectra were acquired 
with 1K complex points, 256 t1 experiments, 32 scans per increment, over a spectral 
width of 13 and 28 ppm in the 1H and 15N dimensions, respectively. HSQC-TOCSY 
spectra were acquired with the same parameters, but with 128 scans per t1 increment and 
a 40 ms DIPSI mixing time. Data were transformed using X-WinNMR (Bruker) and 
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analyzed using CARA (http://www.nmr.ch). 1H chemical shifts were referenced to 
internal DSS. 
 
In vitro binding assay 
 
The rat Dlg-1-deleted mutant derivatives are a kind gift from Lawrence Banks 104. The 
constructs, confirmed by partial sequence analysis, were used for the in vitro expression 
of Dlg proteins. In vitro binding assays were performed in the following fashion: in vitro-
translated, 35S radiolabeled Dlg proteins were incubated at 4 °C for 2 hrs in the presence 
of nickel-sepharose beads to which a recombinant, purified His6-DLL4_IC protein was 
previously conjugated, in the binding buffer (20 mM phosphate buffer, 0.5 M NaCl, 50 
mM imidazole, 5 mM TCEP, protein inhibitor cocktail tablet (Roche), pH 7.4). As a 
negative control, the Dlg proteins were separately incubated with unconjugated beads. 
After extensive washing with the washing buffer (binding buffer added with 1% Tween), 
the beads were collected and the Dlg proteins were eluted from the beads with SDS 
sample buffer, run on a SDS-PAGE gel (12%) and assayed by autoradiography. 
 
Dataset preparation and analysis 
 
A set of human membrane proteins was generated by a search of the Swiss-Prot database 
through the Sequence Retrieval System using “receptor” and “transmembrane” as 
keywords and “single-pass” in the comment field. Entries having type II topology were 
manually discarded from the dataset. The total number of sequences thereby collected 
was 369. This dataset was then divided into two subsets containing intracellular and 
extracellular domains named “intracellular subset” and “extracellular subset”, 
respectively. The boundaries of the domains were sel cted according to the position of 
the transmembrane helix in the sequences as provided in Swiss-Prot. The DisProt 78 
dataset (release 3.6) was downloaded from the Database of Protein Disorder 
(www.disprot.com) and contained 469 entries, while th reduced SCOP dataset was 
created from the SCOP 79 database 1.69 (http://astral.berkeley.edu) by discarding all 
entries with >40% identity, and contained 1357 sequences. Disorder predictions were 
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carried out using DisEMBL 80, IUPred 60, charge/hydropathy plots 81, and amino acid 
compositional analysis 105. DisEMBL (v. 1.5; http://dis.embl.de) was run using the three 
definitions of protein disorder, based on assignments of secondary structure (loops/coils), 
high values of Cα B-factors (hot loops), and missing coordinates in X-Ray structures 
(Remark465). IUPred (http://iupred.enzim.hu/) was run calculating pairwise energies 
within a window of 100 or 25 residues ("long" and "short" disorder definitions, 
respectively). Charge/hydropathy for each sequence was obtained from the absolute value 
of the mean net charge versus the mean residue hydropathy calculated using the 
normalized Kyte-Doolittle scale. Amino acid compositional analysis was carried out 
using Composition Profiler 106 (http://www.cprofiler.org) using the PDB Select 25107 or 
the DisProt 78 datasets as reference for ordered and disordered proteins, respectively. 
Enrichment or depletion in each amino acid type wasexpressed as (Cs1-Cs2)/Cs2, i.e., the 
normalized excess of a given residue's “concentration” in a dataset (Cs1) relative to the 
corresponding value in the other dataset (Cs2). Amino acid types were ranked according 
to increasing flexibility 108. 
 
Disorder predictors used 
 
PONDR 56 (Predictor Of Naturally Disordered Regions) predictors are feedforward neural 
networks that use sequence information from windows f generally 21 amino acids. 
Attributes, such as the fractional composition of particular amino acids or hydropathy, are 
calculated over this window, and these values are used as inputs for the predictor. The 
neural network, which has been trained on a specific set of ordered and disordered 
sequences, then outputs a value for the central amino acid in the window. 
DisEMBL 77 is a neural network-based predictor of disorder that uses three definitions of 
disorder (loops/coils, hot loops or Remark465) as de cribed in the “Dataset preparation” 
paragraph. For each of the three definitions of disor er, a data set was constructed and the 
neural networks trained on each of the three data sets.
IUPred 57 is a predictor that discriminates between ordered and disordered regions based 
on the potential of polypeptides to form stabilizing interresidue interactions, like those 
observed in globular proteins. As the sum of the int raction energies can be approximated 
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by a quadratic expression in the amino acid composition, it is possible to estimate the 
pairwise interaction energies using a set of globular proteins of known structure. The 
calculation involves a 20 X 20 energy predictor matrix, parameterized by a statistical 
method to approach the expected pairwise energy of the globular set. These interactions 
energies can then be used to estimate the energy content of a structurally uncharacterized 
or intrinsically disordered protein region based only on its amino acid composition. 
Comparing globular proteins and disordered ones, a cle r separation in their energy 
content is observed. The approach is turned into a p sition-specific predictor of protein 
disorder that considers only the local (± 2-100 residues) sequential environment of 
residues. The score is averaged over a 21 residue windo . IUPred does not rely on 
networks trained with datasets of disordered proteins, which can be limited in size and 
heterogeneous in terms of experimental conditions; the propensity to disorder estimated 
by IUPred reflects an intrinsic property of certain proteins: the inability to form a number 
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